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High pain-related disability diminishes quality of life and increases health care costs. 
This study evaluated characteristics discriminating between high and low pain-related and 
examined the relationship between factors associated with pain-related disability among 
people with chronic painful temporomandibular disorder (TMD). 
We conducted a cross-sectional analysis of a community-based sample of 1088 
individuals with chronic TMD who completed standardized questionnaires assessing four 
domains: 1) sociodemographic, 2) psychological distress, 3) clinical pain, and 4) 
experimental pain. We used high pain-related disability, classified using the Graded Chronic 
Pain Scale, as the dependent variable in logistic regression modeling to evaluate 
contributions of variables from each domain. Cross-validated area under the ROC curve 
(AUC) quantified model discrimination.  
We re-validated this measure of pain-related disability and created measurement 
models of TMD clinical features, psychological distress, and experimental pain sensitivity. 
Latent variables were combined for a full structural equation model that was crafted with 
exploratory model changes. 
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Participants were 18-44 years old (mean 29.2, SD + 7.8) with a mean duration of 6.9 
(6.4) years of chronic TMD. A third of participants had high pain-related disability. An 18-
variable model encompassing all four domains had good discrimination (AUC=0.79 95% CI 
0.75,0.82), as did a simplified model (sociodemographic variables plus catastrophizing, jaw 
limitation, and number of painful body sites: AUC=0.79 95% CI 0.76,0.82). Duration of 
pain, gender, and experimental pain testing results were not predictive. 
Our structural equation model of pain-related disability, TMD features, and 
psychological distress was created and refined based on exploratory model revisions. 
Estimation of the final model indicated a good fit with the data. TMD clinical features and 
psychological distress predicted pain-related disability but experimental pain sensitivity did 
not. The final model explained 78% of the variance in pain-related disability. 
High-impact chronic pain is a common problem among people with painful TMD. 
Assessment of characteristics associated with high-impact pain can be easily performed to 
identify modifiable risk factors and reduce high-impact pain. TMD clinical features 
(specifically jaw limitation) and psychological distress (including negative affect, 
somatization, and catastrophizing) should be considered by clinicians and researchers 
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CHAPTER ONE: SPECIFIC AIMS 
 
The goal of this study was to understand the epidemiology of pain-related disability 
(also called high-impact pain) among people with painful TMD. The approach was twofold: 
1) to determine characteristics that could be used to distinguish between people with low or 
high pain-related disability and 2) examine relationships between factors associated with 
pain-related disability.  
By studying the impact of pain, we seek to understand the experience of people with 
painful TMD while recognizing the decrease in quality of life and the increase in healthcare 
spending accompanying high pain-related disability. Identifying factors associated with high 
pain-related disability will be useful for clinicians predicting the trajectory of chronic 
orofacial pain and identifying patients at increased risk for disability. Once these 
characteristics are identified, they can be targeted in longitudinal research to understand the 
etiology of pain-related disability and treatment studies aiming to reduce pain-related 
disability. A reduction in high-impact pain among people with chronic pain would thereby 
considerably reduce the public health burden of pain. This is particularly important for 




Aim 1: Explore associations between sociodemographic, psychological distress, clinical 
features, and experimental pain sensitivity domains and high pain-related disability 
among people with chronic TMD. 
 
Hypothesis: Among people with chronic TMD, characteristics indicating more severe pain 
(such as decreased jaw opening limitation and increased pain sensitivity), increased 
psychological distress (high levels of anxiety and depression), additional comorbid 
conditions, and a lack of active coping strategies will allow discrimination between high and 
low pain-related disability.  
Objective: Describe the prevalence of pain-related disability, distinguish between people 
with low or high pain-related disability, and determine factors associated with high pain-
related disability. 
Method: Perform binary logistic regression with the outcome variable of low or high pain-
related disability. Use area under the receiver operator curve indicating sensitivity and 
specificity based on variables representing sociodemographic, psychological distress, clinical 
pain, and experimental pain domains to identify the simplest model with the highest AUC to 
discriminate between people with low or high pain-related disability. 
Aim 2:  Create and evaluate a structural equation model of pain-related disability in 
people with TMD with factors representing psychological distress, clinical TMD 
features, and experimental pain sensitivity. 
 
Hypothesis: Pain-related disability is a multi-faceted construct that potentially involves 
psychological distress including catastrophizing and negative affect, clinical TMD features 
such as jaw opening, and biological pathology measured by experimental pain testing results.  
Objectives: Addressing this aim requires three objectives: 1) re-validate the Graded Chronic 
Pain Scale for measuring pain-related disability with the inclusion of an item measuring 
 3 
presenteeism, 2) create measurement models of latent constructs representing psychological 
distress, clinical TMD features, and experimental pain sensitivity, and 3) develop a well-
fitting structural equation model quantifying the relationship between these latent variables 
while controlling for demographic variables. 
Method: Use structural equation modeling including confirmatory factor analysis for the 
GCPS and measurement models for psychological distress, clinical TMD features, and 
experimental pain sensitivity. Evaluate factor loading onto latent variables representing pain-







CHAPTER TWO: BACKGROUND AND SIGNIFICANCE 
 
 
Painful temporomandibular disorder (TMD) is a chronic pain condition that frequently 
co-occurs with other idiopathic chronic pain conditions involving a variety of bodily pain 
symptoms. Prevalence of TMD symptoms in U.S. adults was 5% in the 2009 National Health 
Interview Survey (NHIS). For people with TMD, average symptom ratings are consistent with 
mild to moderate levels of pain intensity. The Surgeon General’s Report “Oral Health in 
America” (2000) declares, “Oral-facial pain… as a condition in and of itself, is a major source of 
diminished quality of life.” 
The diminished quality of life and pain-related disability resulting from painful TMD 
have been studied in a variety of ways including pain intensity, interference, functional 
limitation, oral behaviors, oral health quality of life, and activities of daily living. Although TMD 
is a localized pain condition, the pain frequently can result in interference and limitations in 
activities directly related to quality of life. This is why the goals of this dissertation are to 
explore and define characteristics associated with high-impact pain among those with 
painful TMD.  This was accomplished with prediction modeling to describe characteristics 
associated with high-impact pain among chronic TMD cases and structural equation modeling of 
pain-related disability.  
Pain-related disability (or high-impact pain) is a complex concept that is a unique 
measurement of the experience of living with chronic pain. These aims are both exploratory and 
hypothesis-testing aims designed to address the epidemiology of high-impact pain among people 
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with localized orofacial pain. Understanding pain impact as a unique factor that may influence 
functioning and progression of disease is very important for understanding the public health 
burden of painful TMD and other comorbid pain conditions that frequently occur in people with 
TMD.  
Definitions of ‘chronic pain’ 
 
The International Association for the Study of Pain (IASP) provides the most widely 
accepted description of pain:  
An unpleasant sensory and emotional experience associated with actual 
or potential tissue damage, or described in terms of such damage. . . . 
Pain is always subjective. . . . It is unquestionably a sensation in a part or 
parts of the body, but it is also always unpleasant and therefore also an 
emotional experience[1]. (emphasis added) 
 
This definition includes the important components of sensory and emotional experiences but do 
not speak to any functional involvement either as an outcome or associated with pain itself.  
Regarding the definition of chronic pain, The Institute of Medicine report on Relieving Pain in 
America states: 
Chronic pain, by contrast, lasts more than several months (variously 
defined as 3 to 6 months, but certainly longer than “normal 
healing”)…[2] 
 
We are focusing our investigation on chronic pain from the standpoint that chronic pain 
can be thought of as an illness itself. The Institute of Medicine states: “Chronic pain has a 
distinct pathology…it has significant psychological and cognitive correlates and can constitute a 
serious, separate disease entity.”[2]. As with other diseases, it is imperative to understand the 
clinical features, morbidity, and disability associated with chronic pain. 
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Aside from duration, there are other characteristics that define a pathological pain state. 
Table 2.1 shows a list of these factors used in pain assessment. It is the consequences of pain that 
we are most interested in, to use the terminology here.  
Table 2.1. Qualities of pain that are frequently measured in chronic pain populations 
The term severity has been used as a synonym for intensity while others have used severity as a description of 
disability. Therefore, I have omitted it from the list of pain symptoms. 
 
Using the biopsychosocial framework to describe pain as impacting the individual as well 
as their role in society, the US National Pain Strategy (NPS) has defined ‘high impact chronic 
pain’ as “persistent pain with substantial restriction of participation in work, social, and self-care 
activities for six months or more”[3]. This definition is similar to the time-frame of chronic pain 
(6 months) of focuses the definition of pain on the impact of the pain. Similar recommendations 
were made in 2014 by the NIH Task Force of Research Standards for Chronic Low Back 
Pain[4], acknowledging the failure to identify causes of pain and instead advocating a shift in 
focus to improving quality of life among people with pain. 
Temporomandibular Disorder 
Painful temporomandibular disorder (TMD) is a chronic condition characterized by pain 
in the jaw joint, face, and masticatory muscles. Although the definition of TMD depends on pain 
Pain symptoms Definition Measurement Instrument Examples 
Intensity (or magnitude) Strength of the painful sensation  Pain rating scales, visual analog scales (VAS) 
Pain site  Where the pain is felt Body diagrams, specific anatomical descriptions 
Time of reference  When the pain was experienced Prevalence measures such as current pain to past 3 
months to pain ever  
Consequences  How pain impacts an 
individual’s activities 
Disability indexes, Short Form-36 (SF-36), daily 
diary measures 
Frequency How often pain episodes occur Number of episodes in a year 
Duration Length of pain since onset  0-6 months, 7 months to 2 years, 3 years or more 
Source Suspected cause of the pain Typically, self-reported, frequently defined in 
exclusionary criteria such as “pain not due to fever or 
menstruation” 
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around the temporomandibular joint, research suggests that TMD is a condition that also 
involves pain in many areas of the body[5]. The Surgeon General’s Report “Oral Health in 
America” declared: 
 “Oral-facial pain… as a condition in and of itself, is a major source of 
diminished quality of life. TMD is considered an idiopathic pain disorder, 
along with several other chronic pain conditions of unknown origin, such 
as fibromyalgia, that are characterized by abnormal motor function, 
autonomic balance, sleep disruption, and neuroendocrine 
irregularities[6].    
 
This quote supports the conclusion above that chronic pain and specifically chronic orofacial 
pain should be considered as a potential source of decreased quality of life with serious 
characteristics listed above that contribute to an illness that goes beyond jaw pain. 
The prevalence of TMD-like pain is measured by the National Health and Interview 
Survey (NHIS) and estimated at 6%[7] in 1989 and 4.6% in data pooled from 2000-2005[8].  
Research addressing the prevalence of other pain and the systemic nature of impairment among 
people with painful-TMD supports the conclusion that while TMD is defined by joint pain, the 
personal experience of this condition likely involves comorbid pain conditions that compound 
impairment. For example, data from 2000-2005 NHIS found that less than 1% of those studied 
reported TMD-like pain without any comorbid headache/migraine, neck, or lower back pain and 
nearly 59% of people with TMD-like pain reported two or more of the following: headache, 
neck, back, and joint pain when asked about severe migraine/headaches, neck, back, and joint 
pain[8]. 
Disability 
The task of defining and measuring health-related disability has a long history in 
medicine, psychology, sociology, and other disciplines. There is extensive literature exploring 
the meaning of disability, which delves into the concept from perspectives of economic, legal, 
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and social implications. Instead, I will explore the concept of disability that is assigned to oneself 
by a person with pain. The definition of disability developed by Nagi[9] and published in 1965 
seems an enduring and succinct model for capturing the dimensions of disability applicable to 
people with chronic pain. Nagi defines disability as an individual’s ability to fulfill “socially 
defined roles and tasks within the environment” within the framework shown below in figure 
2.1. The Nagi model distinguishes disability from functional limitation, pathology, and 
impairment while acknowledging the relationships between the concepts with the use of double-







Figure 2.1. Nagi model of disability. Recreated from Nagi, 1965 
Other conceptual models of disability 
The World Health Organization (WHO) first published the International Classification of 
Impairments, Disabilities, and Handicaps (ICIDH) in 1980, presenting a framework for 
classifying the consequences of disease. As the Nagi model above, the ICIDH model (shown in 





























Figure 2.2. World Health Organization 1980 conceptural model of disease impact 
 
The definitions of the key concepts in the model are shown in table 2.2 and are similar to Nagi’s 
conceptual definitions. In contrast to Nagi’s model, the ICIDH model contains only single-
headed arrows, indicating impairment leads to functional limitation that leads to disability. The 
Nagi model has a more dynamic approach, recognizing that pathology, impairments, limitations, 
and disability can influence one another in bidirectional relationships and also indicating there is 
not a linear process from one variable to the next.  
Table 2.2. Definitions of concepts used in WHO and Locker models  
(adapted from Locker 1992[10] and WHO[11]) 
Concept Definition 
Impairment  
1988 Anatomical loss, structural abnormality or disturbance in biochemical or 
physiological proceesses which arises as a result of disease or injury or is 
present at birth 
2001 Problems in body function or structure such as a significant deviation or loss 
Functional limitation  
1988 Restrictions in the functions customarily expected of the body or its 
component organs or systems 
2001 Functioning refers to all body functions, activities and participation 
Disability  
1988 Any limitation in or lack of ability to perform the activities of daily living 
2001 An umbrella term for impairments, activity limitations and participation 
restrictions 
Handicap  
1988 The disadvantage and deprivation experienced by people with impairments, 
functional limiations, pain and discomfort or disabilities because they cannot 




Locker[12] adapted the ICIDH model (figure 2.3), eliminated the starting point of 
disease, thus emphasizing the impact of intervening variables, and included new pathways. In 
this model, we see pain leading to disability and recognition of intervening variables that can 
influence impairment, limitation, and disability. While Locker’s addition of pain to the model of 
the impact of health is helpful, the model is still restricted to single-headed arrows (other than 
intervening variables) and lacks arrows from limitation to pain and the impact of pain on 
limitation and impairment.  
 
Figure 2.3 Locker’s adapted International Classification of Impairments, Disabilities, and 
Handicaps (ICIDH) model 
 
In 2001, WHO published the International Classification of Functioning, Disability and 
Health (ICF)—replacing the ICIDH as the “framework for measuring health and disability at 
both individual and population levels” (http://www.who.int/classifications/icf/en/)[11]. In this 
publication, the ICF eliminated the term ‘handicap’ and made broad changes to incorporate the 
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biopsychosocial framework of health as opposed to the medical or social models that did not take 
into account the interplay between health and social roles. Figure 2.4 shows the revised  
model published by the WHO in 2001. This model contains double-headed arrows denoting the 
complex relationships between the consequences of disease (impairments, limitations, and 
restrictions) but also a double-headed arrow indicating that health conditions can be influenced 
by limitations. This model represents a substantial improvement on previous models and comes 
the closest to the original Nagi model in terms of related concepts. In my opinion, the conceptual 
diagrams do not require a separate construct representing pain, particularly since pain can be 
defined as an impairment, a disease in itself, and/or a factor that influences limitations and 
restrictions we consider pain caused by another condition.  
 
Figure 2.4. World Health Organization (WHO) International Classification of Functioning, 




Disability and TMD 
 
Disability associated with TMD has been studied using a variety of constructs: oral health 
quality of life (OHQoL), interference, functional limitation, and activities of daily living. We 
selected the most widely used measure of pain-related disability that is well validated and 
reliable: the Graded Chronic Pain Scale (GCPS). Two factors influenced the decision to use this 
measure: the generalizability and use of this scale in chronic pain populations other than TMD 
and the National Pain Strategy’s recommendation for use of a chronic pain screening that 
assesses chronic pain severity and interference[13].  
 The GCPS was developed to measure the extent to which pain is perceived by the patient 
and the degree to which the pain is disabling[14]. The GCPS consists of 3 domains: 
characteristic pain intensity, interference, and disability days. Characteristic pain intensity (CPI) 
includes the average, current, and worst pain rated using a 0-10 Visual Analogue Scale (VAS). 
The interference scale asks about interference rated from 0 to 10 where 0 represents ‘no 
interference’ and 10 represents ‘unable to carry on any activities’. Participants are asked to rate 
interference in three areas of life: 1) daily activities, 2) social, family, recreation, and 3) work 
activities. Disability days are calculated from a question asking how many days pain prevented 
participation in daily activities. These three domains and their subscales are combined to classify 
the chronic pain grade from grade 0 (representing no pain) to grade IV (representing high 
disability and high pain intensity)[15].  
Review of literature 
I performed a systematic review to explore what is known about the relationship between 
TMD and disability. See appendix A for MESH terms and search strategy. Briefly, a Pubmed 
search using search terms related to TMD resulted in 4,121 articles. Searches of CINAHL, Web 
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of Science, and PsyInfo yielded an addition 167 articles that were not duplicates listed in 
Pubmed. Initial filters were used to limit publications to English, research using human subjects, 
research enrolling adults 18 years and older, and elimination of duplicates resulted in 2,650 
articles. All articles measuring pain-related disability and/or OHQoL, as an outcome of TMD or 
orofacial pain were included, requiring review of title titles among the restricted sample of 342 
articles. Next, I reviewed 217 abstracts with the same criteria and further refined the number of 
articles to 178. Review of the 178 articles excluded all review articles, qualitative research 
reports, case studies, commentary, instrument development and validity studies. This left 56 
articles that met the following criteria: human studies which included both TMD classification 
and either pain related-disability or interference assessment. Any study that measured only 
disability related to the jaw and not pain-related disability or a quality of life measure was 
excluded to capture studies concerned with overall disability and not limitations in the jaw area 
only. This limitation lead to a total of 35 studies for review. 
Overwhelmingly, the Research Diagnostic Criteria (RDC) was the preferred method for 
assessing the presence of TMD. One study used the Oral Health Impact Profile (OHIP) and the 
GCPS[16] and reported that among both male and female participants, OHIP scores were higher 
among subjects with higher GCPS scores indicating oral health quality of life was lower among 
people with higher levels of pain-related disability. Another study used both the GCPS and the 
SF-12[17] in a longitudinal examination with follow-up 6 months after enrollment. The authors 
reported lower quality of life scores on the SF-12 were associated with higher chronic pain 
grades and pain intensity measured with the GCPS was the only significant predictor of GCPS 
pain-related disability at 6-months.  
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Among the articles, the major limitations of research are the use of convenience samples 
recruited from orofacial pain clinics or other specialty care facilities and a lack of consistent 
definitions of disability. The literature is reviewed in the next section. 
Case control studies 
The case control studies reviewed can be categorized by the comparison group:  TMD 
compared to healthy controls[16, 18, 19] and people with TMD compared to people with chronic 
pain other than TMD, such as headache[20], neuropathic pain facial pain[21], and other chronic 
pain patients[22]. Among the three studies comparing people with TMD to healthy controls, all 
found TMD patients had significantly impaired functioning compared to healthy controls. All 
studies enrolled TMD patients from specialty or dental clinics except one that recruited a biracial 
(Caucasian and African American) sample of 830 women between the ages 19-23 who were 
screened for facial pain using the GCPS and then examined using the RDC examination for 
verification of TMD status.  The authors report among 85 clinically confirmed cases, 74% had 
no or low pain disability (GCPS scores of 0 or 1) with no racial differences[18]. This is one of 
two articles reporting GCPS grades among TMD cases compared with controls[18, 19] (See 
table 2.3 for the distribution of GCPS among the samples). McKinney and colleagues[22] found 
TMD-only cases had less impairment of activity compared to the non-TMD chronic pain patients 
and overall the researchers concluded chronic TMD patients were behaviorally and 
psychologically similar to non-TMD chronic pain patients. These findings were based on the 
Chronic Pain Battery (CPB), a “multidimensional tool that collects essential medical, 
psychological, behavioral, social, and pain data”, administered to 78 TMD cases compared with 
98 non-TMD chronic pain patients. This finding supports the earlier assertion that pain functions 
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as a disease itself regardless of the anatomical site affected, and that the sequelae are not unique 
to the clinical classification of TMD chronic pain. 
Cross-sectional studies 
Among 14 cross-sectional studies reviewed, the majority used RDC criteria for TMD 
diagnosis with the exception of large population based surveys that relied on self-reported 
symptoms[23].  The majority of the studies used the GCPS to measure disability while one study 
used the MPI[24], and one study used the SF-36 to measure quality of life[25]. Again we see that 
when the OHIP and GCPS are used, there is a strong association between GCPS and mean OHIP 
scores.  
One study enrolled potential community cases: a study of 183 dental students in Brazil 
who were surveyed for orofacial pain symptoms[26]. It is important to note that neither one of 
these studies, nor any other cross-sectional studies, enrolled self-identified TMD cases from the 
community. All studies reported that quality of life measures decreased as pain disability 
increased but also included small numbers of participants who reported pain-related disability. 
Several studies reported low disability among study participants including one study of 
111 patients recruited from a TMD and orofacial pain clinic summarized as: “GCPS scores 
showed that the vast majority of patients had a low disability or no disability at all, with only 
5.4% of patients showing a severely limiting high disability”[27]. Four cross-sectional studies[28, 
29] [30, 31] and two case control studies[18] [19]  reported the distribution of GCPS grade 




Table 2.3. Six research studies reporting GCPS scores by grade 
Grade 0 I II III IV Total 
Citation % % % % % N 
Al-Harthy M, et al. (2010) [28]* 0% 45% 52% 2% 0% 46 
Cioffi I, et al. (2014) [31] 7% 30% 35% 20% 6% 676 
Licini F, et al. (2009) [29] 13% 27% 35% 14% 8% 308 
Plesh O, et al. (2005) [18] 13% 60% 21% 4% 0% 61 
Reissmann, D., et al. (2012) [19] 7% 34% 42% 10% 5% 70 
Xu W, et al. (2011) [30] 22% 51% 18% 8% 0% 162 
* Note:  calculated based on percentages reported in paper 
 
In 2015, Kotiranta[32] reported GCPS-related disability findings among 399 primary care 
patients seeking treatment for TMD. The GCPS was used to classify patients into one of 3 
groups: 61% of the patients were classified as no-disability (GCPS score of 0), 27% to the low-
disability (GCPS I and II) and 12% to the high-disability group (GCPS III and IV). The findings 
supported the use of the GCPS to classify patients with unique psychosocial subtypes and 
concluded the following: 
“…patients in the high-disability group were those reporting the highest 
levels of symptoms of depression and somatization, sleep dysfunction, 
pain-related worry, and catastrophizing/ruminative thoughts. The low-
disability group formed an intermediate group between those patients 
belonging to the no-disability group and those in the high-disability group 
across most variables studied.”[32]  
This is important because this finding represents a dose-response relationship in categories of 
disability. Additionally, this finding supports other research reports that disability is associated 
with poorer overall functioning. If longitudinal research supports the conclusion that disability 
precedes depression, catastrophizing, and sleep disruption, then pain-related disability might be a 
vital indicator to predict quality of life. 
One other study compared people with low to high-disability among 104 patients with 
TMD. RDC criteria were used to confirm TMD status and the GCPS was used to classify 
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patients as low (Grades I or II) or high-disability (Grades III or IV). The authors report patients 
with high levels of pain-related disability had significantly higher depression and somatization 
than those with low levels of pain-related disability[33].  
Multiple studies found an association between pain-related disability, somatization and 
depression[33-37]. Catastrophizing was associated with disability measured using both the 
GCPS[38] and the MPI[24].  
Longitudinal studies 
Eleven longitudinal studies met the criteria for review: 1) enrolled TMD patients and 2) 
measured disability. Six studies used the GCPS to measure disability, two used the MPI, one 
study used both the GCPS and the SF-12[17], one study used the GCPS and the SF-36[39], and 
one study used the CGPS and MPI[40].  
Two studies published by Epker (1999 [41] and 2000 [42]) used similar samples of TMD 
patients referred to research by dentists and oral surgeons. The outcome for each study was 
chronicity of TMD measured with follow-up at 6-months after enrollment. Although the studies 
used RDC verification of TMD status at enrollment, the follow-up appointments at 3 and 6-
months were conducted over the phone, thus introducing potential bias. Researchers were able to 
conclude that the characteristic pain inventory items from the GCPS accurately classified 91% of 
the 144 subjects who went on to develop chronic TMD at follow-up[41] and that the MPI 
interference score at baseline accurately predicted treatment-seeking behavior in 76% of the 
sample of 177 acute TMD patients[42]. 
In a 6-month study of 152 RDC verified TMD patients from a specialty clinic in Sweden, 
Galli[17] found GCPS score at baseline was the only significant predictor of GCPS score at 
follow-up. Pain-related disability could be predicted at the 3-month follow-up by depression and 
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anxiety scales, but this trend did not hold for the 6-month follow-up. Unfortunately, the follow-
up in this study was performed using self-reported questionnaires via mailing instead of a clinic 
appointment with a repeated RDC examination.  
Velly and colleagues (2011) [43] conducted an 18-month prospective study of TMD 
among 480 people with the aim of evaluating the effects of catastrophizing and depression on 
progression of pain-related disability using the GCPS. They found disability score at follow-up 
was related to baseline catastrophizing, depression, widespread pain, and GCPS at baseline. No 
significant association was noted with gender or age. In adjusted analysis including all variables, 
baseline catastrophizing, depression, and GCPS at baseline remained positively related to 
disability score at the 18-month follow-up. A small association was observed between 
widespread pain and disability. A strength of this study is the community-based sample however 
the sample did not have a large group of participants with high level disability, only 12% of the 
population (n=70) at baseline and only 54 people at follow-up met disability criteria. Data from 
the same sample was published one year earlier with the focus of investigation on the effect of 
fibromyalgia and widespread pain on TMD. In their article, the authors report “Baseline 
widespread pain (OR: 2.53, P = .04) and depression (OR: 5.30, P = .005) were associated with 
onset of clinically significant pain (GCPS II-IV) within 18 months after baseline”[44]. 
In 1998, Garofalo published a paper exploring the transition from acute to chronic TMD 
among 153 TMD patients, 87 of which met criteria for chronic TMD at 6-month follow-up. 
GCPS score of III or IV was a predictor of chronicity (patients with higher GCPS scores were 
more likely to be in the chronic group at follow-up) along with an interaction between sex and 
muscle pain (as opposed to disc displacement or other types of joint conditions)[15].  
Phillips and colleagues addressed the effect of gender on 6-month follow-up of acute to 
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chronic TMD status among 233 patients. The authors reported women who developed chronic 
TMD had higher mean scores on the interference score of the MPI but found no significant 
difference among men[40].  
John[45] focused on the association of widespread body pain among 397 patients with 
TMD as a potential risk factor for dysfunctional TMD (which they defined as GCPS score of II 
with any disability points, III, or IV) by performing interviews at enrollment and follow-up at 1 
and 2 years. After controlling for age, education, depression, and baseline GCPS, the authors 
found widespread pain was a risk factor for dysfunctional TMD (OR=1.9). Widespread pain was 
defined as self-reported pain in response to the question: In the last 6 months, have you had a 
problem with back ache or back pain (chest pain, stomach ache or pain, severe headache or 
migraine)?[45].   
Reisine studied the quality of life among 30 TMD patients at their first treatment visit and 
follow-up at 1-month and 6-months after first treatment visit. The MPI was used to assess pain 
interference which was reported to improve 6-months after enrollment[46].  
One study[47] found that 50% of 100 patients improved after 6 months with duration of 
pain being the strongest predictor or lack of improvement. The authors emphasized that no 
psychosocial factors predicted improvement although a number of variables of interest including 
age, gender, anxiety, catastrophizing, and psychological distress were assessed. The authors also 
collected data on widespread pain and jaw limitation and found these variables to not be 
predictive of improvement. Duration of pain, number of healthcare providers seen and reported 
hindrance on function all predicted 6-month improvement[47]. Functional limitation (measured 
using the ‘Patient Specific Approach’ assessed hindrance of function on a 0-100 VAS score) but 
not disability at baseline predicted improvement at 6-months. However, it is important to note 
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that the follow-up measurement was a questionnaire asking the patients if their pain had 
disappeared, decreased, remained the same, or increased.  
Randomized controlled trials 
Six RCTs met the criteria for review: 1) enrollment of people with TMD and 2) 
measurement of disability[48-53]. RCTs were not restricted by intervention and included studies 
of cognitive behavioral treatment (CBT) interventions, biofeedback, and stress reduction 
training. Among these studies, three used the GCPS to measure disability[48, 51, 52, 54], two 
used the MPI[49, 50] and one study used an interference with daily activities questionnaire with 
a 0 to 10 scale[53].  
Rudy and colleagues[50] enrolled 133 patients from a TMD clinic in a 6-week treatment 
with interocclusal appliance therapy as well as 6-week biofeedback relaxation and stress 
reduction treatment. Participants were examined prior to treatment, post-treatment, and 6-months 
after completion of treatment.  The researchers measured disability using the MPI interference 
score and found overall the treatment program was associated with decreased interference when 
pre-treatment and 6-month follow-up were compared. Additionally, the researchers used the MPI 
to categorize patients into one of three groups: dysfunctional, interpersonally distressed, and 
adaptive copers. The dysfunctional group was characterized by psychological distress and high 
levels of pain-related interference. This dysfunctional group demonstrated the most improvement 
from therapy compared to the other two groups. This finding suggests patients fitting the 
dysfunctional profile assessed by the MPI would benefit the most from standard therapy with 
biofeedback and stress reduction treatment.  
Turner[53] enrolled 139 TMD patients (classified by self-reported facial ache or pain in 
the temporomandibular joint) from an HMO or specialty clinics to participate in a study 
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comparing standard treatment to standard treatment with cognitive behavioral therapy. Disability 
(defined as interference due to pain on a 0 to 10 scale), depression, pain, coping strategies, and 
jaw opening were measures pretreatment and at 3- and 12-month follow-up. The authors reported 
that at 3-month follow-up, demographic variables, treatment group, and belief/coping measures 
did not predict pain interference with activities when pre-treatment pain interference was 
controlled for statistically. This finding indicates pain interference at follow-up may have been 
linked to a variable not measured.  
Three studies limited enrollment to patients with a GCPS score of 2 or higher (Dworkin 
2002 [48], Turner 2006 [52] and Turner 2007 [51]) recruited from specialty clinics. All three 
studies used the RDC to verify TMD patient status and the GCPS to measure disability. 
Dworkin[48] compared usual treatment (described as physiotherapy, patient education, 
medications, and occlusal appliance therapy) with usual treatment plus a 6-session cognitive 
behavioral intervention and measured variables at baseline, post-treatment follow-up at 6- and 
12-months. The authors reported the CBT intervention was effective in improving pain-related 
interference. They also reported depression severity measured at baseline was associated with 
pain interference at baseline, but not as much with interference at one-year follow-up.  
In 2006, Turner[52] reported results from a study of 156 TMD patients randomized to 
CBT or a control patient education group and found “the proportion of patients who reported no 
interference at 12 months was nearly three times higher in the CBT group than in the control 
group”. In a publication one year later, Turner[51] reported pain-related beliefs mediated CBT 
effects on disability at one-year follow-up among 115 TMD patients.  
A single RCT enrolled people with RDC verified TMD from the community. In this 
study, 101 people were recruited with community advertisements and randomized to standard 
 22 
treatment or standard treatment plus CBT and were assessed at post-treatment (6 weeks), 12, 24, 
36, and 52-weeks. The main finding indicated somatization moderated the effect of treatment on 
pain-related interference measured by the MPI[49]. This finding supports the conclusion that 
somatization is involved predicting pain-related disability. 
Conclusions 
In summary, this literature review has identified four themes that warrant further 
investigation and that have motivated the aims and methods planned for this study: 1) disability 
has been associated with the following characteristics: depression, somatization, catastrophizing, 
and anxiety, 2) there is a paucity of research involving community based TMD cases, 3) few 
studies have focused on pain-related disability in a sample that is diverse and can be stratified by 
gender, race, and other identified variables, and 4) no studies have reported disability results in 
conjunction with clinical findings other than jaw limitation.  
The aims of this dissertation were intended to address identified gaps in the research by 
using established and validated scales to measure pain-related disability among community 
dwelling cases. The variables included in analysis allowed for conclusions about pain sensitivity, 
clinical features of pain in the face as well as in the body in addition to exploring the role of 
variables that have been identified in previous research. This choice allows for a validation of 
previous findings while also considering variables that have not been previously explored—
specifically experimental pain sensitivity. The large sample size permits multiple comparisons 
and examination of the role of multiple sociodemographic characteristics that may not have been 
present in the majority of the reviewed literature. Finally, we seek to explore the relationships 
between these factors as measured using latent variables that can contribute to the understanding 
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CHAPTER THREE: RESEARCH DESIGN AND METHODS 
Study Population 
Men and women ages 18-44 were recruited into the parent study from four sites: NC, 
NY, FL, and MD. The four study sites are all centered in east coast college towns but represent 
rural and urban populations with varying demographics. The source population was the counties 
surrounding the study sites. Table 3.1 shows demographic characteristics of the study sample. 
Individuals with major medical conditions such as kidney disease, heart disease, chronic 
respiratory disease, uncontrolled hypertension, epilepsy and/or uncontrolled diabetes were 
excluded. Also, hospitalization for psychiatric treatment within the previous 6 months was 
exclusionary. The gender and ethnicity enrollment was designed to reflect demographic 
characteristics in the major counties surrounding the four study sites.  
Prospective participants responded to recruiting materials seeking volunteers with jaw 
pain while healthy controls were recruited for a “study of muscle and jaw function” and had no 
history of jaw pain. It is possible that the sample is not representative of orofacial pain in the 
community, particularly if people who volunteer for research studies are fundamentally different 
than those who would not be willing to participate in a research study. The importance of 
studying a community-based sample as opposed to recruiting specifically from orofacial pain 
clinics and dental clinics allows for greater generalization to the community dwelling people 
with chronic TMD. This is a problem faced by most research studies and the OPPERA study is 
not immune to the potential bias introduced when random sampling cannot answer the research 
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question. However, the relatively large sample size should provide results that are generalizable 
to people with TMD.  
Although duration of pain was not associated with disability in preliminary analysis, 
people with onset TMD may have had less time to develop coping strategies, less experience 
with treatment seeking, and other factors that may distinguish them and provide insight into the 
onset period where intervention might be most effective. 
Table 3.1. Demographic variables describing the data from the OPPERA study of 1088 chronic 
TMD cases. 
Characteristic N Column % 
Gender   
Male 253 23.3 
Female 835 76.7 
Age (years)   
18-24 385 35.4 
25-34 395 36.3 
35-44 308 28.3 
Race/Ethnicity   
White 765 70.3 
Black or African American 175 16.1 
Asian 45 4.1 
Hispanic 66 6.1 
Other/not stated 37 3.4 
Study Site   
Chapel Hill, NC 342 31.4 
Buffalo, NY 247 22.7 
Gainesville, FL 271 24.9 
Baltimore, MD 228 21.0 
Study Design 
I addressed the stated aims using chronic TMD cases recruited as part of the case control 
design of the Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) study. 
Aims 1 and 2 utilized data from the cross-sectional study of 1088 people with chronic examiner 
verified TMD. The next section details each aim with the corresponding research question, 




Aim 1: Explore associations between sociodemographic, psychological distress, clinical 




What characteristics are associated with high levels of disability?  
Rationale 
Understanding factors associated with high disability in a large cross-sectional study has 
implications for understanding disability longitudinally. Knowing more about characteristics that 
are common among people with high disability is useful for clinicians tailoring interventions to 
reduce disability and targeting modifiable factors that may influence disability level.  
Objectives  
We used binary logistic regression to discriminate between low and high pain-related 
disability groups. We undertook a model-building strategy that started with demographic 
variables and then built upon this model by adding variables addressing the domains of 
psychological distress, TMD clinical features, and experimental pain sensitivity. We evaluated 
the models using area under the curve values to determine the best discriminatory model.  
 
Aim 2:  Create and evaluate a structural equation model of pain-related disability in people 
with TMD with factors representing psychological distress, clinical TMD features, and 
experimental pain sensitivity  
 
Research Question 





Identifying the factors associated with increased disability is vital for improving targeted 
interventions and reducing the burden of chronic TMD. 
Objectives 
 The primary goal was to fit a model with latent variables measuring pain-related 
disability, psychological distress, experimental pain sensitivity, and clinical TMD features. First, 
I re-validated the GCPS with the inclusion of a variable measuring presenteeism. Second, I 
created measurement models for psychological distress, experimental pain sensitivity, and 
clinical TMD features based on self-report and clinically measured observed variables. 
Subsequently, I fit a full SEM with pain-related disability, psychological distress, experimental 
pain sensitivity, and clinical TMD features.  
Outcome assessment: Pain-related disability 
Graded Chronic Pain Scale 
The Graded Chronic Pain Scale (GCPS) contains 7 items asking participants about pain 
intensity, interference in daily activities, and disability days (days with decreased or impaired 
functioning). These seven items are used to calculate a score from 0 to IV. Grade 0 indicates no 
pain, grade I is defined as pain of low intensity, grade II-low and grade II-high refer to high 
intensity pain with low grade II referring to no disability and high grade II indicates the presence 
of disability, grades III and IV represent moderate and significant pain-related disability 
(independent of pain intensity) respectively. A middle cut-point has been recommended to 
distinguish between low and high levels of disability using the GCPS[1]. This cut-point replaces 
previous recommended use of grades I and II to denote low and grades III and IV as described in 
the literature review above. This cut-point has been used in research since 2002 to distinguish 
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between low and high-disability as well as functional and dysfunctional status[1]. The GCPS has 
an established cut-point that is widely accepted and used in clinical research[2]. 
Previous research reported the prevalence of pain-related disability among people with 
TMD measured with the GCPS range from 2%[3] to 41%[4]. The expected prevalence of 
disability using the GCPS cut-point in this sample was 35% based on preliminary analysis. The 
GCPS has been used to evaluate pain-related disability in a number of research studies including 
studies of TMD[5, 6] and has been reported to be a reliable and valid instrument[7, 8].  We used 
the dichotomous cut-point of low vs. high to address aim one and created a continuous latent 
variable of pain-related disability based on all components of the GCPS in the analysis used for 
aim two. 
Covariate assessment 
Covariates included a mix of self-reported and clinical measurements variables 
representing the following domains: sociodemographic, clinical TMD features, psychological 
distress, and experimental pain sensitivity. Each measure is shown in table 3.2 with a description 











Table 3.2. Variables with description and coding 




Age Self-reported in years Continuous 18-44  
Gender Self-reported at enrollment Binary 0 = male 
1 = female 
Race/Ethnicity Self-reported at enrollment Nominal 
categorical 
0 = White non-Hispanic 
1 = African American 
2 = Hispanic 
3 = Asian 
4 = Other including multi-
racial 
Study site Assigned based on initial interview for 




0 = UNC 
1 = UB 
2 = UMD 
3 = UFL 
Psychological distress 
Positive affect Profile of Mood States (POMS-Bi) 
Positive Affect summary score 
Continuous 30-120 
Negative affect POMS-Bi Negative Affect summary 
score 
Continuous 30-120 
Somatic symptoms SCL-90R Somatization scale Continuous 0-4 
Catastrophizing Coping Strategies Questionnaire (CSQ-
R) catastrophizing subscale 
Continuous  0-6 
Clinical TMD features 
Jaw opening Maximum unassisted opening measured 
in millimeters 
Continuous 0-70mm 
Jaw limitation Jaw Functional Limitation Scale (JFLS) 
Global measure scale 
Continuous 0-10 
Oral parafunctions Oral Behavior Checklist (OBC)  Continuous 0-84 
Pain duration Years since pain onset  Continuous 0-99 
Number of painful body 
sites 
Number of body sites reported as painful 
upon examination 
Continuous  0-14 
Number of comorbid 
conditions 
CPSQ count of presence of 20 self-




Experimental pain sensitivity 
Thermal tolerance Thermal pain threshold and tolerance Continuous  32-52° C  
 
Pressure pain threshold Pressure pain threshold (trapezius) kPa Continuous 50-600 kpa 





Difference in pain rating from single 
stimulus to series of ten  
Continuous -13.7-80 






Statistical analysis applied conventional epidemiologic methods to address the stated 
aims with the primary outcome measure of disability as defined using the GCPS. Both aims were 
limited to a sample of prevalent chronic TMD cases. Aim 1 evaluated factors are associated with 
prevalence of high pain-related disability among people with chronic TMD. Aim 2 evaluated a 
model of pain-related disability using structural equation modeling.  
Among continuous variables we explored the distribution of the variable among people 
with high and low disability and performed t-tests to compare mean scores by disability status. 
Additional univariate statistics were generated with stratified contingency tables. In the case of 
binary and categorical variables, I used a defined a reference value. Among continuous variables, 
I explored the distribution to determine appropriate cut-points. However, since there are not 
previously defined cut-points for the continuous variables, I used tertiles in order to make 
comparisons based on low, medium, and high groups.  
Missing data was evaluated for each variable and compared by tertile and outcome (low 
disability vs. high disability). Participants who completed less than half of the items in a 
questionnaire were not included in analysis. In the group with at least 50% completion, multiple 
imputation was performed using the expectation maximum method before I obtained the 
datasets. As a sensitivity analysis, I performed a complete case analysis restricted to participants 
with complete data for all variables included in the full regression model (n=846) and then 
compared results to a more complete sample (n=1014) of participants with complete data for all 
variables in the selected model. Secondly, I compared both results to data after performing 
multiple imputation. Discrepancies were evaluated. The extent of missing data between people 
with low and high disability was examined.  
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Statistical power 
Aim 1 addressed factors useful in discriminating between people with low or high pain-
related disability. Aim 2 explored factors contributing to the latent variable of pain-related 
disability. Aim 1 involved hypothesis testing assuming a background disability prevalence of 
20%. Given the study sample size of 1,046 with complete data for the outcome of interest, this 
study would have 80% statistical power for detecting differences in prevalence ratios comparing 
low and high disability above the level of 1.4 and greater. See Figure 3.1. For example, in a 
reference population with prevalence of 0.30, a prevalence ratio of 1.6 has 80% power. 
 Figure 3.1. Statistical power curves for aim 1 calculated using SAS 9.3 
 
The SEM for aim 2 was adequately powered given the ratio of sample size to number of 
parameters to be included in the model. Using a calculator for sample size, I tested several 
parameters and found that with a desired statistical power level of 0.80 and an anticipated effect 
size of 0.3, a SEM with 7 latent variables and 20 observed variables with a probability level of 
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0.05 requires a minimum sample size of n=170 to detect effect and a recommended sample size 
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CHAPTER FOUR: CHARACTERISTICS ASSOCIATED WITH HIGH-IMPACT PAIN 
IN PEOPLE WITH TMD: A CROSS-SECTIONAL STUDY1 
 
Overview 
Background: High-impact (disabling) pain diminishes quality of life and increases health 
care costs. This study aims to evaluate the characteristics that distinguish between high and low-
impact pain among individuals with painful temporomandibular disorder (TMD). 
Methods: Community dwelling adults (n=846) with chronic TMD completed standardized 
questionnaires assessing four domains: 1) sociodemographic, 2) psychological distress, 3) 
clinical pain, and 4) experimental pain. We used high-impact pain, classified using the Graded 
Chronic Pain Scale, as the dependent variable in logistic regression modeling to evaluate 
contributions of variables from each domain. Cross-validated area under the ROC curve (AUC) 
quantified model discrimination. 
Results: One third of participants had high-impact pain. Sociodemographic variables weakly 
discriminated between low and high-impact pain (AUC=0.61, 95% CI 0.57, 0.65) with the 
exception of race. An 18-variable model encompassing all four domains had good discrimination 
(AUC=0.79, 95% CI 0.75, 0.82), as did a simplified model (sociodemographic variables plus 
catastrophizing, jaw limitation, and number of painful body sites): AUC=0.79, 95% CI 0.76, 
0.82). Duration of pain, gender, and experimental pain testing results were not predictive. 
                                                
1 Manuscript submitted for review as: Miller, V., Poole, C., Golightly, Y., Barrett, D., Chen, D., 
Ohrbach, R., Greenspan, J., Fillingim, R., and Slade, G., Characteristics associated with high-




Conclusion: High-impact chronic pain is a common problem among people with painful 
TMD. Assessment of characteristics associated with high-impact pain can be easily performed to 
identify modifiable risk factors and reduce high-impact pain.  
1 Introduction  
TMD is a public health problem 
Temporomandibular disorder (TMD) is characterized by pain in the jaw joint, face, and 
masticatory muscles that can become chronic. Although the hallmarks of TMD, as a regional 
pain disorder, are pain in the temporomandibular joints and masticatory muscles, people with 
TMD often experience pain in many other areas of the body[1]. 
Population-level prevalence of TMD range from approximately 5-10%, though case 
definitions vary among studies. Based on a single-item question, The National Health and 
Interview Survey (NHIS) estimated TMD-like pain at 6% in 1989[2] and 4.6% in data pooled 
from 2000-2005[3].  A representative sample of an urban population in Brazil found 9.2% of 
people reported experiencing at least 3 TMD symptoms[4].  The prevalence of TMD combined 
with the paucity of effective treatments, and the likelihood of comorbid conditions such as 
headache and other idiopathic pain conditions, result in a significant individual and public health 
burden. For example, high-impact pain measured by Graded Chronic Pain Scale (GCPS) is 
predictive of healthcare spending. Specifically, among orofacial pain patients, movement from 
low to high GCPS status results in a $5252increase in healthcare costs over 6 months[5]. 
  
                                                
2	The reference reported 2012 £366 which we converted to 2012 US dollars using 
http://eppi.ioe.ac.uk/costconversion/  (last accessed February 27, 2018).   
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High-impact pain 
The National Pain Strategy identified as a target “Reducing the prevalence of high-impact 
chronic pain and its associated morbidity and disability”[6]. However, the extent of TMD-related 
disability is disputed. In a study of nursing students with signs or symptoms of TMD, 93.7% 
reported not having sought treatment, of whom nearly half (46%) reported that they were not 
bothered by the symptoms[7]. The authors inferred that the symptoms were not a problem for 
these individuals and concluded “most subjects with clinically detectable dysfunction are 
functioning adequately without significant symptoms” (p. 295) [emphasis added]. In one study of 
399 TMD patients, only 49 (12%) met criteria for high-pain related disability[8]. Reported 
prevalence of pain-related disability classified using the established taxonomy of Graded 
Chronic Pain Scale (GCPS) among people with TMD range from 2%[9] to 41%[10]. Using the 
same outcome assessment to obtain vastly different prevalences warrants further investigation. In 
truth, the extent of the problem of high-impact pain among people with chronic TMD is 
unknown. 
Research exploring pain-related disability among people with TMD has identified multiple 
potential characteristics associated with disability. Researchers have reported an association 
between pain-related disability, somatization and depression[11-15]. Catastrophizing has been 
associated with high pain-related disability[16, 17]. Pain intensity and disability points have been 
associated with anxiety, somatization and depression[18]. Along with depression and 
somatization, duration of pain was linked to pain-related disability in Dutch, Italian, and Israeli 
samples[19]. Limitations of previous observational studies include potential selection bias from 
recruitment of participants from specialty pain clinics as some other factor may influence both 
treatment-seeking and pain-related disability. Many studies have reported a low number of 
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people experiencing high pain-related disability. Small sample size has prevented thorough 
examination of multiple factors in the respective population.  
The purpose of this study was to identify variables from four domains that are associated 




This cross-sectional study comprised 1088 people with chronic TMD recruited between 
May 2006 and October 2013 addresses characteristics associated with high-impact pain. The 
sample was nested in the parent study, the Orofacial Pain: Prospective Evaluation and Risk 
Assessment (OPPERA; Slade et al 2011[20]). The parent OPPERA study included a case-control 
study that compared chronic TMD cases with TMD-free controls. Human Research Ethics 
Committees at all study sites approved the study protocol. All participants signed an informed 
consent for study participation. Participants were compensated for their time. 
Participants 
Participants were community dwelling individuals living near one of four study sites 
(University at Buffalo, NY, University of Florida Gainesville, FL, University of Maryland in 
Baltimore, MD, and University of North Carolina at Chapel Hill, NC) of the OPPERA study. 
Participants responded to advertisements seeking people with chronic jaw pain. Participants were 
aged 18-44 years and were required to be fluent in English. Exclusion criteria included recent 
facial surgery or facial injury, pregnancy, orthodontic procedures or major medical conditions 
including kidney disease or uncontrolled hypertension. For more details about recruitment and 
sociodemographic composition of participants from each study site see Slade et al.[20].  
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Participants completed a telephone interview to assess eligibility prior to completing a 
battery of questionnaires about psychological distress and clinical pain, and a 3-hour clinic visit 
including clinical examination for verification of TMD status and experimental pain testing. Of 
the 1088 TMD cases recruited, 1042 had data for the outcome of interest and hence were 
included in the current study (see figure 4.1). See supplemental material for a diagram of 
participants contacted, eligible and consented.  
Procedures 
Chronic TMD was defined as self-reported facial pain symptoms experienced for at least 6 
months prior to enrollment and fulfillment of examination criteria described below. The 6-month 
threshold is consistent with the definition of chronic pain provided by the Institute of Medicine: 
“Chronic pain, by contrast, lasts more than several months variously defined as 3 to 6 months, 
but certainly longer than ‘normal healing’”[21]. Potential participants had to report pain in the 
cheeks, jaw muscles, and/or jaw joints for at least 15 days in the prior month and at least 5 days 
per month for the previous 5 months. The Research Diagnostic Criteria for TMD (RDC/TMD) is 
a structured clinical examination conducted by a calibrated investigator who obtained 
measurements of jaw movement, records joint sounds, and palpates muscle and joint sites to 
determine the classification of painful TMD or normal[22]. This examination was based on the 
established guidelines of the RDC/TMD[23].  
Outcome assessment: Disability 
We measured pain impact using dichotomized scoring from the Graded Chronic Pain Scale 
(GCPS). The GCPS contains 7 items to assess pain intensity, interference in daily activities, and 
disability days (number of days with decreased or impaired functioning). These seven items were 
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used to calculate five, hierarchical categories: grade 0 to grade IV[24]. Categories were 
subsequently dichotomized to denote low-impact (GCPS grades IIa-low or less) or high-impact 
(GCPS grades IIb-high or more) following the algorithm developed by Dworkin[25].  The GCPS 
has been used to evaluate pain-related disability in a number of research studies including studies 
of TMD[26, 27] and has been reported to be a reliable and valid instrument[24].   When the 
GCPS was published, the researchers used the term “pain-related disability” but recently the 
National Pain Strategy’s Population Health Strategy for Pain report indicates that high-impact 
pain and pain-related disability refer to the same construct.  
Explanatory variables 
The multidimensionality of pain impact was assessed using variables from multiple 
domains. Sociodemographic data were collected upon entry (study site, age, self-reported sex 
and racial identity). Psychological distress variables measured positive and negative affect, 
catastrophizing, and somatic symptoms. Clinical pain features represent a mix of self-report 
measures related to jaw function such as jaw limitation and oral parafunction behaviors, and 
variables obtained during clinical examination. Experimental pain variables were collected 
during laboratory sensory testing. Although not previously explored in research addressing pain 
impact, experimental pain sensitivity has been linked to clinical pain expression[28]. 
Explanatory variables fit into four domains: sociodemographic, psychological distress, clinical 
pain, and experimental pain sensitivity. This categorization is consistent with domains of interest 
defined by OPPERA investigators[29].  
Jaw mobility and painful body sites 
Examiners measured two aspects of jaw function that were not part of the RDC/TMD 
criteria for case classification: 1) maximum unassisted opening and 2) number of painful body 
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sites. Instructions for the unassisted mouth opening measurement were “Open as wide as you can 
even if you feel pain or increase any pain you are feeling” and opening distance was measured in 
millimeters.  To assess the number of painful body sites, pressure was applied to seven sites 
bilaterally including: the trapezius, supraspinatus, second rib, lateral epicondyle, medial gluteus, 
greater trochanter, and medial knee[23].  At each site, three pounds of pressure was applied. The 
respondent reported pain or no pain at each site for a sum score from 0-14.  
Jaw limitation 
The Jaw Functional Limitation Scale (JFLS) is a self-administered 20-item instrument 
that measures limitations in three areas: chewing limitation, vertical jaw mobility or opening 
limitation, and limitation in verbal and emotional expression[30]. Participants were asked to rate 
their limitation in activities such as “chew tough bread” and “open wide enough to bite into a 
sandwich” using a 0 to 10 scale where 0 represented no limitation and 10 indicated severe 
limitation. The JFLS can also be used to calculate a combined global measure of jaw limitation. 
We used the global functional limitation measure as an overall summary of jaw limitation.  
Oral Parafunction/Jaw overuse behaviors 
The Oral Behavior Checklist (OBC) is a 21-item instrument to assess the frequency of a 
variety of oral parafunctional behaviors such as grinding the teeth at night, chewing gum, and 
sustained talking[31]. The participants were asked to report how often they engage in these 
behaviors answering with ordinal responses from 0 to 4 indicating the frequency of the behavior. 




Comorbid pain conditions 
Participants completed a questionnaire that asked about the presence or absence of 20 
conditions: joint disease or arthritis, fibromyalgia, chronic fatigue syndrome, irritable bowel 
syndrome, tendency to faint, ringing in ears, periodic heart racing or pounding, repeated trouble 
with neck, back, or spine, insomnia, depression, panic disorder, post-traumatic stress disorder, 
anxiety disorder, acid reflux, interstitial cystitis, prostatitis, multiple chemical sensitivity, 
dysmenorrhea, chronic pelvic pain, and sleep apnea. We used a sum score ranging from 0-20 
corresponding to the number of conditions positively endorsed by participants.  
Duration 
Participants reported the time (in years and months) since facial pain began. Duration was 
intended to measure the time since initial onset of the condition and not the time elapsed during 
the most current pain episode. A separate question was asked of participants to describe the 
pattern of duration of pain using the following categories: persistent, recurrent, or a single 
episode that had since ended.  
Psychological Distress 
Positive and Negative affect 
Participants completed the Profile of Mood States-Bipolar (POMS-Bi), a 72-item 
inventory used for assessing mood profiles. The scoring produces 6 dissimilar phases of mood 
that can be summed into two scores: overall positive affect and overall negative affect[32]. 
These scores capture the multiple domains assessed with the POMS-Bi including feelings of 
confidence, confusion, hostility, anxiety, and depression. We hypothesized the negative 
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summary score would encapsulate anxiety and depression that may be associated with high-
impact pain. 
Catastrophizing 
Catastrophizing was classified according to the catastrophizing subscale of the Coping 
Strategies Questionnaire (CSQ-R). The CSQ-R is a revised version of the original CSQ[33] 
which consists of 27 items relating to how individuals cope with pain. Participants indicate the 
frequency with which they engage in specific coping activities when experiencing pain, using a 
7-category numerical scale ranging from 0 (never do that) to 6 (always do that). The 
catastrophizing subscale is comprised of 6 questions indicating negative statements such as “I 
worry all the time about whether it will end”.  This subscore addresses the concept of pain-
related worry previously reported to be associated with high levels of pain-related disability[8]. 
Somatic symptoms 
Participants completed the Symptoms Checklist 90-Revised (SCL-90R), a 90-item self-
report inventory of symptoms the participant may have experienced. Participants were instructed 
to answer how much each problem distressed or bothered them during the past 7 days with the 
following ordinal scale: not at all, a little bit, moderately, quite a bit, or extremely. These items 
were scored 0 to 4 accordingly. The SCL-90R includes a somatization subscale that consists of 
questions about headaches, chest pain, lower back pain, nausea, sore muscles, faintness, trouble 
getting your breath, hot or cold spells, numbness, a lump in the throat, feeling weak in parts of 
the body and feeling heaviness in arms or legs[34].  
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Experimental pain  
Thermal tolerance 
A commercially available thermal stimulator (Medoc, Israel) was placed on the 
participant’s arm, producing temperature increasing at a steady rate of 0.5oC/second. Participants 
were asked to click a mouse button when they no longer wished to tolerate the pain from the heat 
and this temperature was recorded as the thermal tolerance. This procedure was repeated four 
times and the average was recorded as the participant’s thermal tolerance.  
Pressure pain threshold 
Pressure pain thresholds were measured using a pressure algometer (Somedic, Sweden) 
placed on multiple body sites. The participants were given instructions to press a button when 
he/she first felt a sensation of pain from pressure. The rating is a single number, the average from 
two ratings on each side of the body reported in kilopascal units of pressure. For the analysis 
reported here, we used the pressure threshold measured on the trapezius. This site was selected to 
capture pain sensitivity outside the orofacial area. The trapezius site has been defined as a 
fibromyalgia tender point[35] and therefore may be a marker for widespread body pain. 
Mechanical pain rating and mechanical temporal summation  
Mechanical pain ratings and temporal summation of mechanical pain were assessed using 
a flat-tipped weighted pinprick stimuli applied to the skin. Participants were asked to rate the 
sensation from the weighted stimuli using the 0-100 pain intensity scale. Temporal summation of 
pricking pain was tested with the weighted mechanical probe applied in a series of ten 
applications over 10 seconds. Again, participants were asked to rate the pain intensity evoked by 
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the series of stimuli using the 0-100 scale. Temporal summation was calculated as the difference 
between the rating of the series-of-10 stimuli and the rating of the single stimulus.  
Data analysis 
The outcome of interest was dichotomous pain-related disability score, classified using 
the GCPS. Student’s t-tests were used to compare the mean values of continuous variables 
between low and high disability groups. Correlations between pairs of continuous variables were 
computed using Spearman’s rank correlation coefficient to identify variables that should be 
excluded from analysis due to potential for multi-collinearity. There were no variables with 
correlation higher than 0.7 thus none were excluded. For descriptive purposes, tertiles of 
continuous variables were used to establish low, medium, and high-levels because category cut-
points have not been previously defined. Categorical variable classification was used for 
frequency and stratified analysis. 
Binary logistic regression was used to evaluate associations between high-impact pain 
and the associated risk variables comprising sociodemographic, psychological distress, clinical 
pain, and experimental pain domains. Prevalence odds ratios from logistic regression were used 
to calculate area under the ROC curve (AUC) statistics in order to provide a simple numeric 
summary of a multivariable model’s ability to discriminate between people with low- vs high-
impact pain. To address the problem of overfitting when calculating AUC, we used a cross-
validation method for estimating prediction error by creating divisions of the dataset for training 
and validation of the fitted model. The process involves simulation of model fitting without 
observations and then using that model-fit result to compute the result for the previously 
excluded observations[36].  Cross-validation is a more efficient substitute for the classic method 
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of splitting a dataset and using one section to create the predictive model and then testing the 
model in the other section.  
The model building strategy started with a model including only sociodemographic 
variables (i.e. Model 1 in Table 4.4). Subsequent models explored the additional contributions of 
variables corresponding to the following domains: psychological distress (Model 2), clinical pain 
(Model 3), and experimental pain (Model 4). Model 2 included model 1 variables plus 
psychological distress variables: positive and negative affect scores, somatization subscale, and 
catastrophizing subscale. Model 3 included all variables from previous models with the addition 
of clinical pain variables: JFLS global score, OBC summary score, maximum unassisted 
opening, number of painful body sites, duration of condition, and the number of comorbid pain 
conditions. Model 4 included all variables from previous models with the addition of 
experimental pain sensitivity testing results: thermal tolerance, pressure pain threshold of the 
trapezius, pain rating of mechanical stimulus, and mechanical stimuli windup.   
Akaike Information Criterion (AIC) and Bayesian Information Criteria (BIC) were used 
to compare model fit. The AIC provides information about goodness of fit among these models. 
The BIC penalizes for more variables in the model and thereby complements the AIC by 
addressing the potential estimate inflation as the number of parameters increases. The model 
with the lowest BIC can be interpreted as the model with the maximum posterior probability[37].  
The model with the highest cross-validated AUC represents the best model for discriminating 
between people with low- or high-impact pain. We considered an increase in AUC equal to or 
greater than 0.05 to indicate a substantial change.  Deleting variables and assessing the AUC for 
change in estimate quantified the role of individual variable contribution to the model. This 
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process resulted in the selected model (Model 5 in Table 4.4). Statistical significance of the 
difference between two models was also measured to compare the models. 
To address potential sex differences indicated by previous research, the sample was 
stratified by sex and selected models were re-run in each population. Changes in the AUC 
between males and females would indicate a need to develop separate models based on sex.  
Missing data 
Figure 4.1 shows the STROBE diagram of missing data from the sample of 1088 people, 
resulting in the final complete case sample restricted to 846 people. Participants with any 
missing data for the variables included in the modeling procedure were excluded from all 
analyses. Only 4% of the full sample exhibited missing data for the outcome of interest. Sample 
B shows restriction to the 99% of the sample that had complete data for addressing psychological 
distress variables (n=13). Sample C is restricted to 95% of Sample B when people with missing 
data about clinical pain features (n=52) were excluded. The final study sample was 87% of 
Sample C as the largest exclusion was due to missing experimental pain data (n=131). The 
percentage of participants with missing data were compared between low- and high-impact pain 
groups, according to variables used in the analyses.  Chi-square tests were used to evaluate 
differences between groups. Individual items missing from questionnaires were imputed using 
the expectation-maximization (EM) algorithm in the datasets available for this analysis. 
OPPERA investigators describe the method in the following way: “In general, if a subject 
skipped at least 1 but less than half the items in a questionnaire, the missing items were imputed. 
If they failed to complete at least half of the items in the questionnaire, we treated their summary 
score as missing”[38]. 
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We used SAS software Version 9.4 of the SAS System for Windows to perform all analyses. 
Copyright © 2012 SAS Institute, Cary, NC. 
3 Results 
Descriptive data 
One third of the study participants (33.5%) reported characteristics consistent with high-
impact pain indicating interference with their day-to-day activities. The mean age of participants 
was 29.0 years (SD 7.8). The ratio of female to male participants in both categories of disability 
was 3:1. Over 70% of the sample identified as white, while 14% of the sample identified as 
Black or African American.  
We created tertiles to compare differences in the distribution of people among in high, 
medium, and low levels of explanatory variables and compared the distributions among people 
with high-impact pain compared to low-impact pain. Forty-one percent of the low-impact sample 
was in the 18-24 age range while 30% of the high-impact group was in this age category, 
indicating older people were more likely to experience high-impact pain. There were 
race/ethnicity differences by impact with 76% of the low-impact group identifying as white 
while 62% of the high-impact group was white. Twenty-five percent of the high-impact group 
identified as Black or African American. Sex distribution by impact was very similar. There 
were more women than men in the sample of cases, with the 3:1 female to male ratio observed in 
both low and high-impact groups. People with low-impact pain scored higher on the POMS 
positive affect scale and lower on the negative affect scale. There were similar patterns for 
catastrophizing, somatic symptoms, jaw functional limitation, and oral parafunction behavior 
with the low-impact group demonstrating lower scores and higher scores among the high-impact 
group indicating a higher level of distress and impairment. Other variables did not present with a 
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monotonic relationship among the low, medium and high groups. The percentage of people with 
the lowest number of painful body sites among people with low impact was 35%, then 37% in 
the medium group and 28% for the highest group while the high impact group was distributed in 
the low, medium, and high categories at 32, 25, and 45% respectively.  
The mean history of orofacial pain was 7.0 years (SD 6.4). Among people with high-impact 
pain, the mean duration was 7.4 years while the low-impact group had a mean duration of 6.7 
years with standard errors of 7.6 and 8.0 years respectively. Approximately 70% reported having 
ever seen a health care provider for facial pain. Among people with high compared to low-
impact the frequency of reported treatment seeking was 76% and 67% respectively (not shown).  
Among people with high-impact pain, the mean number of painful body sites was 7 while 
people with low-impact indicated a mean of 5 sites (rounded to the nearest whole number to 
represent pain sites). Table 4.2 shows people with low-impact pain reported one less painful 
condition from the 20 conditions compared to people with high-impact pain. Experimental pain 
testing results indicated people with low-impact pain demonstrated higher pressure pain 
thresholds measured on the trapezius, rated the mechanical probe less painful, and had less wind-
up with the mechanical probe compared to the high-impact group.  
Comparison of models 
The initial multivariate model included sociodemographic variables: race, age, sex, and 
study site. These variables represent the minimum of controlling for study design and 
sociodemographic characteristics that may be associated with high-impact pain compared to 
models accounting for multidimensional aspects of high-impact pain. The area under the curve 
(AUC) of model 1 was 0.61, somewhat better than chance (0.50). Self-reported race was 
associated with parameter estimates of high-impact pain with individuals identifying as Black or 
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African American more likely to experience high-impact pain compared to people who identified 
as white. People who identified as Asian, Hispanic, other or multiple racial or ethnic groups did 
not have elevated estimates of high-impact pain. There did not appear to be an effect of age or 
gender. Compared to the Chapel Hill study site, people living in Gainesville had similar odds of 
high-impact pain while people living in either Buffalo or Baltimore had higher odds of high-
impact pain.  
Model 2 was comprised of 8 variables: 4 variables from model 1 plus 4 variables 
representing psychological distress:  overall positive affect and negative affect scores from the 
POMS, the SCL-90R somatization subscale and CSQ-R Catastrophizing subscale score. While 
the POMS scores seemed to have no contribution to increasing the AUC, increased somatization 
and catastrophizing scores were associating with increased pain impact.  
Model 3 included all variables from model 2 with the addition of 6 variables measuring 
clinical pain features including the combined global jaw functioning limitation score, oral 
behavior checklist, jaw opening, number of painful body sites, number of comorbid conditions, 
and duration of pain. Among the added variables, increases in jaw functional limitation and 
number of painful body sites were the only variables associated with an increase in impact. 
Model 4 is the full model, including all variables in model 3 plus the 4 experimental pain testing 
variables: thermal tolerance, pressure pain threshold, mechanical pain rating, and mechanical 
pain windup. Although temporal summation of mechanical pain and mechanical pain rating had 
different means by impact group in univariate analyses, the logistic regression model showed no 
independent association with high-impact pain.  
Based on the findings of the hierarchical model building process, we constructed a 
parsimonious selected model (model 5) designed to achieve the highest AUC with the lowest 
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number of variables. This model included sociodemographic variables, catastrophizing, jaw 
limitation, and painful body sites. Though age and gender were not associated with impact, these 
variables were retained in the selected model because they have been identified as variables of 
interest in prior research. Also, though somatic symptoms were associated with high impact, 
removing this variable from the selected model did not cause a reduction in the AUC. Table 4.5 
shows the results from all 5 models and figure 4.2 shows all curves. Despite overlap in the 95% 
confidence intervals for AUC from models 2, 3, 4, and the selected model, the chi-squared p-
value comparing model 4 to the selected model and model 3 to the selected model were not 
statistically significant (p=0.83 and p=0.64 respectively).  
Because models 3 (the model containing all sociodemographic, clinical pain and 
psychological distress variables) and 4 (the full model) were so similar in cross-validated AUC, 
we turned to model BIC and AIC to assess model fit. The AIC decreased from 1001 (model 2) to 
872 with the addition of clinical variables (model 3). The smaller value, indicating better fit, did 
not fluctuate much with the addition of the experimental pain sensitivity variables (model 4) or 
the reduction in variables in the selected model (AIC= 871). The BIC decreased with the addition 
of mood variables (936), and again slightly with clinical variables (967), but increased with 
experimental pain variables indicating the penalty for additional variables that did not increase 
the model fit. The selected model had the lowest BIC (933).   
Finally, when we ran models 4 and 5 stratified by sex, we found the AUC from model 5 
was identical for both men (n=194) and women (n=652). When model 4 was performed with sex 




Missing data results 
Approximately one fifth of subjects (19%) had incomplete data for one or more variables 
used in this analysis (Table 4.3). There was some variation in the percentage with incomplete 
data among racial groups, but no differences by age or sex.  The Florida study site had the most 
complete data.  The percentage of people with incomplete data increased as catastrophizing 
increased (p=0.03) and differed according to jaw function (p<0.0001), although not in a 
monotonic manner. There was no statistically significant difference between missing and 
complete data by positive and negative affect scores, somatization score, oral behavior checklist 
sum score, maximum unassisted opening, reported duration of pain, pressure pain threshold, or 
mechanical pain testing.  
Frequency of incomplete data varied according to the number of painful body sites and 
the number of comorbid painful conditions. There was less missing data in the highest thermal 
tolerance category. In summary, missing data was related to overall increased severity and 
symptoms, indicating that individuals with more comorbid pain conditions may have been less 
likely to complete all study components.  
Because we performed complete case analysis, the sample was limited to n=846. As the 
selected model did not include experimental pain testing results which were the variables 
accounting for the most missing data, the model was repeated using the original sample with 
missing data only from the variables included in the model. This yielded a sample of n=1014 and 
an AUC of 0.79, 95% CI (0.76, 0.82) and BIC=1115. The results of multiple imputation for 
model 4 (the full model) was 0.80 (with individual imputations AUC ranging from 0.79 to 0.80), 
95% CI (0.77, 0.83), SE=0.01. These results are nearly identical to results from the complete 
case analysis. We performed a sensitivity analysis using data from a more complete sample 
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(Sample B in figure 4.1). The results of the selected model in this larger population (n=1014) 
were the same AUC. We also performed multiple imputation and we found the AUC measure to 
be robust. 
4 Discussion  
Key Results 
This is the first large study addressing the distinction between levels of pain impact among 
community dwelling people with TMD. We found that catastrophizing, jaw functional limitation, 
and tenderness to body palpation were useful tools for discriminating between high- and low-
impact pain. Specifically, people with TMD who reported greater pain catastrophizing, increased 
jaw limitation, and more painful body sites were more likely to experience high-impact pain than 
low-impact pain.  Our selected model containing sociodemographic variables, catastrophizing, 
jaw limitation, and painful body sites performed as well as the full model with all 18 variables. 
The high-performing selected model with 3 major predictors represents a simplified model of 
high-impact pain focused on 3 unique characteristics that can easily be evaluated in a clinical 
setting.  
Interpretation 
It is important to note that, even though we used a predictive modeling approach, the 
parameter estimates cannot be interpreted as causal as the data is cross-sectional and we have not 
controlled for confounding. The model building strategy was designed to assess the contribution 
of variables to the ability to discriminate between high- and low-impact pain, therefore the goal 
was the highest AUC achieved with the simplest model. Consistent with the TRIPOD 
statement[39], we have produced the first step in prediction by testing predictive performance in 
one data set. The large cross-sectional study provided an adequate number of chronic TMD cases 
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in order to make multiple comparisons by identified variables of interest. The next step for 
understanding the etiology of pain impact requires a longitudinal setting that should be informed 
by the findings presented here.   
Previous research implicated depression, pain duration, female gender, and 
somatization[12] as contributors to pain-related disability. We found no effect of gender or pain 
duration on pain impact. Restricting the sample by sex and running both the full and selected 
models further explored the effect of gender. These results indicated no differences between men 
and women in the application of the selected model.  
We found Black or African American people were more likely to experience high-impact 
pain compared to other racial or ethnic categories including Asian, Hispanic, and Caucasian. 
Previous research has identified racial difference in clinical as well as experimental pain[40]. In 
univariate analyses, people who identified as Black or African American were older than 
participants from other racial groups and reported higher scores on catastrophizing and jaw 
limitation, but not more painful body sites. In a model of pain impact using race as the single 
predictor, people identifying as Black or African American had 3.5 times the odds of having 
high-impact pain compared to whites (AUC=0.34, 95% CI (2.4, 5.2)). Univariate findings 
suggest that African Americans in this sample were more likely to report features that we found 
associated with high-impact pain. However, the relatively small number of African Americans in 
the sample (n=120) is a limitation of this finding. Future research is needed to address race 
inequalities and pain impact to understand this relationship.  
Limitations 
Due to the cross-sectional nature of the study, the prediction model is diagnostic as 
opposed to prognostic. The cross-sectional design does not permit conclusions about whether or 
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not high-impact pain is caused by functional limitation and catastrophizing or if the reverse could 
be true. The age range of 18-44 is a potential limitation because the sample over-represents 
younger people with TMD. The narrow age range of participants is likely not representative of 
the entire population living with chronic orofacial pain. Additionally, there is the likelihood that 
unmeasured variables could have improved upon the performance of the predictive model.  
Somatic symptoms were of interest because somatization has been associated with pain-related 
disability in previous research[41], but the specific measurement of somatization in this study 
heavily influenced the decision to exclude it from the final model. A randomized controlled trial 
of 101 community-dwelling people with TMD assessed the effects of cognitive behavior therapy 
(CBT) at multiple time points after treatment and found somatization moderated the effect of 
treatment on pain-related interference[42]. That study used the same measure of somatization 
that we used: the SCL-90R. Our findings are consistent with previous research findings 
identifying an association with the SCL-90R somatization scale and high-impact pain, but the 
somatization scale was not included in the final model because the measure did not improve the 
AUC and other measures of somatization analyzed were not associated with high-impact pain 
(results not shown).  
Missing data were an issue that required careful attention. Our examination of 
missingness was illuminating in two ways. We observed potential patterns in the data related to 
missingness and severity of the condition or symptoms. Based on sensitivity analysis and 
multiple imputation results, we conclude that the AUC is a robust measure that remained 
unchanged under different approaches to address missingness. 
Generalizability 
A major strength of this study is the community-dwelling sample. As opposed to a 
clinical sample recruited from tertiary pain clinics, participants in this study represent varying 
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levels of treatment seeking and therefore, the results should be generalizable to the larger 
population of people with painful TMD. Approximately 70% of the sample reported having ever 
seen a healthcare provider for facial pain. The frequency of reported treatment seeking was 
75.9% and 66.6% among people with high- and low-impact pain, respectively. This result points 
to the conclusion that almost a quarter of people meeting the criteria for high-impact pain 
reported never having seen a healthcare provider for treatment.  
A second strength of our approach is the unique comprehensive assessment of study 
participants. In addition to self-reported questionnaire data, we were able to include an 
exploration experimental pain sensitivity testing. The extensive data collection allowed for a 
very thorough assessment of multiple dimensions that could influence pain outcomes.  
Although experimental pain testing may have usefulness in clinical practice for identifying 
subgroups of patients[43] or predicting post-operative pain[44], our results support the 
conclusion that experimental pain testing has limited ability to differentiate high-impact from 
low-impact TMD pain.  
The Federal Strategy for Pain report says: “High-impact chronic pain is associated with 
substantial restriction of participation in work, social, and self-care activities for six months or 
more”[45]. The report recommends an assessment of high-impact pain based on the response to 
3 questions about how often people experience interference due to pain in “usual work, regular 
social and recreational activities, and taking care of myself” with the answers never, rarely, 
sometimes, usually or always. Based on this scale, high-impact chronic pain is defined as at least 
one of the 3 items rated “usually” or “always”. The difference in this proposed method and the 
GCPS used in our research is the GCPS asks participants to rate extent, rather than frequency, of 
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interference on the 0 to 10 scale and the GCPS classification is also based on pain intensity and 
work days missed.  
Managing high-impact pain is imperative for clinicians treating chronic TMD. 
Information about characteristics associated with high-impact pain therefore is valuable 
clinically for targeting and modification to improve patient outcomes. Several research studies 
have produced evidence that CBT and biofeedback training may reduce pain impact[25, 46, 47]. 
For example, patients who received combined CBT and biofeedback training experienced greater 
change in pain-related disability measured with the GCPS compared to the control group[46]. 
When “usual treatment” (described as typically physiotherapy, patient education, medications, 
and occlusal appliance therapy) was compared with usual treatment plus a 6-session cognitive 
behavioral intervention, researchers found pain-related interference was reduced among those 
receiving CBT but the benefit was temporary[25]. In a sample of 115 TMD patients, researchers 
reported pain-related beliefs mediated CBT effects on disability at one-year follow-up[47].  
In conclusion, the current study demonstrated an association between catastrophizing, 
jaw functional limitation, and painful body sites with high-impact pain while gender, duration of 
condition, and experimental pain sensitivity were not associated with high-impact pain. We 
found that one third of people with chronic TMD experienced high-impact pain and that 
catastrophizing, jaw limitation, and painful body sites were associated with high-impact pain 
while pain duration, gender, and experimental pain sensitivity were not. This finding is 
consistent with the hypothesis that pain impact is a complex construct associated with clinical 
pain features as well as ability to cope with pain. Assessing catastrophizing and jaw functional 
limitation requires two brief questionnaires while assessing painful body sites can be performed 
with a brief physical exam. Understanding and improved targeting of catastrophizing, jaw 
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limitation, and body pain for therapeutic intervention is important to reduce the impact of pain 
among people with chronic TMD.  
 
Funding: This work was supported by the National Institutes of Health (NIH)/National Institute 





Table 4.1. Demographic and clinical characteristics of the sample of people with chronic TMD. 
Pain-related disability classification: high-impact is GCPS II-high, III, IV (n=283) and low-impact is GCPS I and II-
low (n=563). 
  Low-Impact Pain (n=563)  
High-Impact Pain 
(n=283) 
  Total N %   N % 
Race/Ethnicity  
     White 604 429 76.2
 
175 61.8
Black/African American 120 49 8.7 
 
71 25.1 
Asian 38 29 5.2 
 
9 3.2 
Hispanic 56 38 6.8 
 
18 6.4 
Other 28 18 3.2 
 
10 3.5 
Age (years)  
     18-24 314 229 40.7
 
85 30.0
25-34 305 205 36.4 
 
100 35.3 




     Male 194 126 22.4
 
68 24.0
Female 652 437 77.6 
 
215 76.0 
Study site   
     UNC 239 177 31.4
 
62 21.9
UB 201 122 21.7 
 
79 27.9 
UF 237 173 30.7 
 
64 22.6 
UMD 169 91 16.2 
 
78 27.6 
UNC= University of North Carolina at Chapel Hill; UB=University of Buffalo, NY; UFL=University of Florida at 
Gainesville; UMD=University of Maryland at Baltimore 
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Table 4.2. Continuous variables in the sample of people with chronic TMD by pain impact 
classification 
 
Low-impact is GCPS I and II-low and high-impact is GCPS II-high, III, IV.  






 Mean SD Mean SD Mean SD P-value† 
Age (years) 29.0 7.8 28.2 7.6 30.5 8.0 <0.001 
POMS: Overall positive affect* 80.7 16.2 82.0 15.8 78.0 16.7 0.008 
POMS: Overall negative affect* 58.2 18.8 56.0 17.5 62.6 20.4 <0.001 
Catastrophizing* 0.7 0.6 0.6 0.5 1.0 0.7 <0.001 
Somatization* 1.4 1.2 1.1 1.1 2.0 1.3 <0.001 
JFLS global measure* 2.0 1.5 1.6 1.3 2.9 1.7 <0.001 
OBC total score* 32.8 11.0 31.9 10.2 34.7 12.2 0.001 
Maximum unassisted opening (mm) 46.9 8.9 47.3 8.4 46.2 9.8 0.085 
Number of painful body palpation sites 5.8 4.0 5.4 3.6 6.6 4.5 <0.001 
Number of pain comorbid conditions 2.6 2.6 2.2 2.1 3.6 3.0 <0.001 
Duration of pain (years) 6.9 6.4 6.7 6.2 7.4 6.7 0.155 
Thermal tolerance (oCelsius)* 45.6 2.4 45.7 2.3 45.3 2.5 0.029 
Pressure pain threshold: trapezius (kPa)* 278.8 125.0 288.5 127.9 259.5 116.7 0.001 
Mechanical probe pain rating* 11.8 14.8 10.3 11.9 15.0 19.0 <0.001 
Mechanical temporal summation* 13.4 14.5 12.1 13.0 15.8 16.8 0.001 
Abbreviations: POMS, Profile of Mood States: Bi-polar Form; JFLS, Jaw Functional Limitation Scale; OBC, Oral Behaviors Checklist 
*Variable includes imputation of up to 50% missing items †P-value from t-test comparing low- and high-impact pain groups 
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Table 4.3. Results of binary logistic regression models predicting presence of high-impact pain 




Model  1 + 
psychological 
distress 
Model  2 + 
clinical pain 
features 






Number of subjects 846 846 846 846 846 
AUC 0.65 0.76 0.81 0.82 0.80 
AUC cross validated 0.61 0.74 0.79 0.79 0.79 
95% CI 0.57, 0.65 0.70, 0.77 0.75, 0.82 0.75, 0.82 0.76, 0.82 
SE 0.02 0.02 0.02 0.02 0.02 
Model BIC 1088.36 935.53 967.32 985.68 932.53 
Model AIC 1040.95 1001.90 872.51 871.90 870.90 
Race (ref= white) 
     Asian 0.92 (0.40, 1.94) 0.86 (0.34, 1.96) 0.99 (0.38, 2.36) 0.86 (0.32, 2.08) 1.00 (0.38, 2.34) 
Black 2.83 (1.83, 4.39) 2.64 (1.64, 4.28) 2.74 (1.63, 4.63) 2.39 (1.40, 4.10) 2.72 (1.64, 4.54) 
Hispanic 1.24 (0.67, 2.22) 1.19 (0.61, 2.25) 1.24 (0.63, 2.39) 1.09 (0.54, 2.11) 1.22 (0.62, 2.34) 
Other 1.38 (0.59, 3.03) 1.32 (0.55, 3.03) 1.36 (0.52, 3.32) 1.23 (0.47, 3.09) 1.39 (0.54, 3.41) 
Age 1.02 (1.00, 1.04) 1.02 (1.00, 1.04) 1.02 (1.00, 1.05) 1.03 (1.00, 1.06) 1.02 (1.00, 1.05) 
Sex (ref=male) 
     Female 1.07 (0.75, 1.54) 1.07 (0.72, 1.60) 0.92 (0.59, 1.45) 0.90 (0.57, 1.45) 0.84 (0.55, 1.30) 
Study site (ref=UNC) 
     UB 1.68 (1.12, 2.55) 1.29 (0.82, 2.04) 1.35 (0.83, 2.19) 1.48 (0.91, 2.41) 1.35 (0.84, 2.18) 
UF 1.06 (0.69, 1.61) 1.04 (0.66, 1.63) 1.18 (0.74, 1.90) 1.14 (0.69, 1.88) 1.16 (0.73, 1.86) 
UMD 1.70 (1.09, 2.67) 1.49 (0.92, 2.43) 1.72 (1.00, 2.95) 1.74 (1.00, 3.03) 1.70 (1.00, 2.91) 
POMS: Overall Positive Affect*  
 
1.00 (0.99, 1.01) 1.00 (0.99, 1.01) 1.00 (0.99, 1.01)   
POMS: Overall Negative 
Affect*  
 
1.00 (0.99, 1.01) 1.00 (0.99, 1.02) 1.00 (0.99, 1.02)   
Somatization*  
 
2.04 (1.47, 2.84) 1.54 (1.04, 2.30) 1.52 (1.02, 2.26) 
 Catastrophizing* 
 
1.59 (1.37, 1.84) 1.45 (1.24, 1.70) 1.46 (1.24, 1.71) 1.46 (1.25, 1.70) 
JFLS Global Measure*  
  
1.63 (1.44, 1.86) 1.63 (1.44, 1.87) 1.59 (1.41, 1.79) 
OBC total score* 
  
0.99 (0.98, 1.01) 0.99 (0.98, 1.01)   
Maximum unassisted opening  
  
1.01 (0.99, 1.04) 1.01 (0.99, 1.04)   
Number of painful body sites 
  
1.08 (1.03, 1.13) 1.07 (1.01, 1.13) 1.08 (1.03, 1.13) 
Number of comorbid conditions  
  
1.03 (0.95, 1.13) 1.02 (0.94, 1.12)   
Duration of pain (years) 
  
1.00 (0.97, 1.03) 1.00 (0.97, 1.03)   
Thermal tolerance (oCelsius)  
   
0.99 (0.92, 1.08)   
Pressure pain threshold*  
   
1.00 (1.00, 1.00)   
Mechanical probe pain rating* 
   
1.01 (0.99, 1.02)   
Mechanical temporal 
summation*        1.02 (1.00, 1.03)   
Abbreviations: AUC, Area under the curve; CI, confidence interval; BIC, Bayesian information criteria; AIC, 
Akaike information criteria; UNC, University of North Carolina at Chapel Hill; UB, University of Buffalo, NY; UF, 
University of Florida at Gainesville; UMD, University of Maryland at Baltimore, POMS, Profile of Mood States: 
Bi-polar Form; JFLS, Jaw Functional Limitation Scale; OBC, Oral Behaviors Checklist; kPA, kilopascals 








Table 4.4. Comparison of models  
      
ROC Model AUC SE LCL UCL BIC 
Model 1 (4 variables) 0.6118 0.02 0.57 0.65 1088.36 
Model 2 (8 variables) 0.7360 0.02 0.70 0.77 953.53 
Model 3 (14 variables) 0.7853 0.02 0.75 0.82 967.32 
Model 4 (18 variables) 0.7861 0.02 0.75 0.82 985.68 
Selected model (7 variables) 0.7873 0.02 0.76 0.82 932.53 
Model 1 includes race, age, gender, and study site. Model 2 includes model 1 variables and mood 
variables. Model 3 includes model 2 variables and clinical jaw features. Model 4 includes model 
3 variables and experimental pain testing. Selected model includes model 1 and JFLS, 















Figure 4.2. The cross-validated AUCROC comparing the selected model to models with 
demographic variables and patient characteristics.  
 
The full model is shown as the first model, represented by a solid line. Model 1 includes race, gender, age, and study 
site. Model 2 includes demographics plus mood variables. Model 3 includes demographics plus mood and clinical 
variables. The selected model includes race, age, gender, study site, catastrophizing, JFLS score, and number of 





Table 4.S.1 Demographic and clinical characteristics of the sample with complete (n=846) and 
missing data (n=196) 
 







Impact    
Low 563 16.7  
High 283 22.7 0.02 
Race/Ethnicity    
White 604 18.2  
Black/African American 120 26.4  
Asian 38 11.6  
Hispanic 56 12.5  
Other 28 17.7 0.05 
Age (years)    
18-24 314 15.6  
25-34 305 19.5  
35-44 227 22.0 0.10 
Sex    
Male 194 18.5  
Female 652 18.9 0.88 
Study site     
UNC 239 26.9  
UB 201 17.3  
UF 237 9.5  
UMD 169 19.5 <0.0001 
POMS7: Overall Positive Affect*†     
Low (0-72.9) 263 19.8  
Medium (73.0-87.9) 276 17.9  
High (88.0-120.0) 307 18.6 0.81 
POMS8: Overall Negative Affect*†    
Low (0-46.9) 283 17.3  
Medium (47.0-64.9) 278 17.8  
High (65.0-120.0) 285 21.1 0.27 
Somatization*†    
Low (0.-0.3) 297 15.6  
Medium (0.4-0.8) 251 19.8  
High (0.9-4.0) 298 19.0 0.34 
Catastrophizing*†    
Low (0-0.6) 275 14.1  
Medium (0.6-1.8) 274 18.7  
High (1.8-6.0) 297 22.3 0.02 
JFLS Global Measure*†    
Low (0-1.16) 286 17.1  
Medium (1.17-2.6) 298 11.3  
High (2.7-10.0) 262 24.7 <0.0001 
OBC total score*†    
Low (0-27.0) 276 16.6  
Medium (27.1-36.9) 274 18.0  
High (37.0-84) 296 20.1 0.33 
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Maximum unassisted opening† (MM)     
<44 279 19.1  
44-51 278 13.9  
>51 289 18.8 0.14 
Number of painful body palpations 
sites† 
   
0-3 286 14.1  
4-7 279 14.2  
8-14 281 24.3 0.0002 
Number of pain comorbid conditions†    
0 199 14.2  
1-3 411 16.1  
4-20 236 21.6 0.05 
Duration of pain† (years)    
0-2.9 304 18.7  
3-7.9 244 18.9  
8.0-35.0 298 18.8 0.99 
Thermal tolerance*† (oCelsius)    
0-44.8 267 17.1  
44.9-46.6 295 12.1  
46.7-53.0 287 10.0 0.02 
Pressure pain threshold Trapezius*†  
(kPa)  
   
0-202.2 272 14.7  
202.3-303.7 278 12.6  
303.8-600.0 296 10.6 0.28 
Mechanical probe pain rating*†      
0-3.0 273 15.5  
3.1-11.1 279 16.7  
11.2-100 294 15.5 0.88 
Mechanical windup*†       
-13.7-4.6 281 14.6  
4.7-13.6 267 18.6  
13.7-85.0 298 14.6 0.27 
*Denotes variable includes imputation of up to 50% missing items. †Categorical variable delineations refer to 












Figure 4.S.1. Recruitment flowchart of 896 participants with chronic TMD enrolled between 
2011 and 2013.  
This sample was used to supplement the original 192 chronic cases that were enrolled in the 
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CHAPTER FIVE: EXPLORING THE RELATIONSHIP BETWEEN FACTORS 
ASSOCIATED WITH PAIN-RELATED DISABILITY IN PEOPLE WITH PAINFUL 




Background: Pain-related disability is a sophisticated construct that refers to impact on 
individual functioning and can fluctuating based on unknown factors. Disability is common 
among people with chronic temporomandibular disorder (TMD). The purpose of this research 
was to examine the relationship between factors associated with pain-related disability among 
people with chronic TMD.  
Methods: We conducted a cross-sectional analysis of a community-based sample of 1088 
individuals with chronic TMD who had complete data. We re-validated a measure of pain-related 
disability and created measurement models of TMD clinical features, psychological distress, and 
experimental pain sensitivity. Latent variables were combined for a full structural equation 
model that was modified using exploratory model changes. 
Results: Participants were 18-44 years old (mean 29.2, SD + 7.8) with a mean duration 
of 6.9 (6.4) years of chronic TMD pain. A model of pain related disability, TMD features, and 
psychological distress was created and refined based on exploratory model revisions. Estimation 
of the final model indicated a good fit with the data. TMD clinical features and psychological 
distress predicted pain-related disability but experimental pain sensitivity did not. The final 
model explained 78% of the variance in pain-related disability. 
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Conclusions: TMD clinical features (specifically jaw limitation) and psychological 
distress (including negative affect, somatization, and catastrophizing) should be considered by 
clinicians and researchers addressing pain-related disability.  
1 Introduction  
Background 
Painful temporomandibular disorder (TMD) is defined by localized pain involving 
masticatory muscles and associated limitation in jaw function. People with TMD report pain in 
the face, jaw, temple, and ear. The National Health and Interview Survey (NHIS) estimated the 
prevalence of TMD-like pain in the US population at 4.6%, based on data pooled from 2000-
2005[1].  The experience of living with jaw pain can involve not only discomfort but also 
distress from its effect on everyday life, including work and social restrictions[2]. The negative 
impact of living with temporomandibular disorder pain on quality of life has been well 
established[3, 4].  
Research addressing the prevalence of other pain conditions among people with TMD 
and the systemic nature of impairment among people with painful TMD supports the conclusion 
that while TMD is defined by jaw pain, the personal experience likely involves comorbid pain 
conditions that compound impairment. For example, NHIS data from 2000-2005 found that more 
than 99% of those with TMD-like pain also reported comorbid headache/migraine, neck, or 
lower back pain, and nearly 59% reported having at least two more areas of severe pain[1]. 
Disability 
The task of defining and measuring health-related disability has a long history in 
medicine, psychology, sociology, and other disciplines. There is extensive literature exploring 
the meaning of disability and its economic, legal, and social implications. Here, we explore the 
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subjective experience of disability, drawing on the classic definition by Nagi[5] (1965) that 
explores people’s ability to fulfill “socially defined roles and tasks within the environment.” 
Nagi’s model (shown in figure 5.1) distinguishes disability from functional limitation, pathology, 
and impairment while acknowledging the interrelationships between the concepts.  
Other conceptual models of disability 
The World Health Organization (WHO) first published the International Classification of 
Impairments, Disabilities, and Handicaps (ICIDH) in 1980, presenting a framework for 
classifying the consequences of disease. Like the Nagi model above, the ICIDH model (shown in 
5.2) does not include pain as a factor in the depiction of disability.  
Definitions of the key concepts in the model are shown in Table 5.1 and are similar to 
Nagi’s conceptual definitions. In contrast to Nagi’s model, the 1980 ICIDH model contains only 
single-headed arrows, indicating that impairment leads to functional limitation, which leads to 
disability. The Nagi model has a more dynamic approach, recognizing that pathology, 
impairments, limitations, and disability can influence one another in bidirectional and nonlinear 
relationships among variables.  
In 2001, the WHO published the International Classification of Functioning, Disability 
and Health (ICF)—replacing the ICIDH as the “framework for measuring health and disability at 
both individual and population levels” (http://www.who.int/classifications/icf/en/)[6]. In this 
publication, the ICF eliminated the term ‘handicap’ and made broad changes to incorporate the 
biopsychosocial framework of health as opposed to the medical or social models that do not take 
into account the interplay between health and social roles. Figure 5.3 shows the revised model 
published by the WHO in 2001. This model contains double-headed arrows denoting the 
complex relationships among impairments, limitations, and restrictions and indicating health 
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conditions can be influenced by limitations. This model represents a substantial improvement 
from the 1980 model with the exclusion of the term ‘handicap’ and the recognition of 
interrelatedness between impairment, limitations and restriction. Additionally, the 2001 model 
comes closest to the original Nagi model in terms of related concepts.  
In my opinion, the conceptual diagrams do not require a separate construct representing 
pain, particularly since pain can be defined as an impairment, a disease in itself, and/or a factor 
that influences limitations and restrictions. However, this can lead to confusion since the ICF 
reference framework links questions about pain interference to the concept “pain as a body 
sensation”[7, 8] indicating pain interference is a symptom or a consequence of disease or a health 
condition. When applying the ICF framework to chronic pain conditions, it should be noted that 
when chronic pain is the health condition being modeled, then impairment, restriction, 
environmental factors, and personal factors might influence the severity of pain symptoms.  
Disability and TMD 
Disability associated with TMD has been studied using a variety of constructs: oral health 
related quality of life, interference in daily activities, functional limitation, and activities of daily 
living. In this study, we selected the most widely used measure of pain-related disability that is 
well validated and reliable: the Graded Chronic Pain Scale (GCPS). Two factors influenced the 
decision to use this measure: the generalizability and use of this scale in chronic pain populations 
other than TMD and the National Pain Strategy’s recommendation for use of a chronic pain 
screening that assesses chronic pain severity and interference[9].  
 The GCPS was developed to measure the extent to which pain is perceived as intense 
and/or interfering by the patient and the degree to which the pain is disabling[10]. The GCPS 
consists of 3 domains: characteristic pain intensity, interference, and disability days. 
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Characteristic pain intensity (CPI) includes the average, current, and worst pain rated using the 
0-10 Visual Analogue Scale (VAS).  Pain intensity is measured as 0 to 10, with 0 representing 
‘no pain’ and 10 referencing ‘pain as bad as it could be’.  Interference is rated from 0 (no 
interference) to 10 (unable to carry on any activities) in three areas of life: 1) daily activities, 2) 
social, family, and recreation, and 3) work activities. Disability days are calculated using a 
question about the number of days in which pain prevented participation in daily activities. 
These three domains and their subscales are combined to represent a “chronic pain grade” from 0 
(no pain) to IV (high disability and high pain intensity)[11].  
Among people with orofacial pain, high pain-related disability is associated with 
increased healthcare spending quantified by an average increase of £366 ($444 USD) over 6 
months when moving from a low to high GCPS category[12]. However, the causes of pain-
related disability among people with orofacial pain are not understood. By improving 
understanding of factors associated with pain-related disability, we can create better 
interventions to improve or prevent pain-related disability among people with TMD.  
Previous studies 
Previous research has identified associations between psychological functioning and 
pain-related disability among people with TMD. Specifically, catastrophizing[13-15], 
depression[16-18], and somatization (physical symptoms thought to be related to anxiety)[19, 
20] are associated with increased disability.  
Structural equation modeling was used because the constructs of disability, psychological 
distress, jaw features, and experimental pain sensitivity all refer to characteristics that are not 
directly observable. Instead, we use latent constructs comprised of self-reported questionnaire 
data, physical examination, and laboratory testing to capture data representing these variables. 
 81 
Structural equation modeling (SEM) is a useful tool for analysis because it allows the researcher 
to create latent variables representing constructs that cannot be directly observed. The constructs 
and relationships shown in the ICF model can be analyzed using latent variables. Latent 
variables can include measured variables such as items on a questionnaire or a summary score 
that we believe measures the construct of interest. Confirmatory factor analysis (CFA) is used to 
determine if observed data fit a defined model. 
Several research studies have used SEM to examine the relationships depicted in the 
WHO ICF model[21-25].  In a longitudinal setting, researchers tested temporal relationships 
among physical impairment (pain), activity and participation restrictions in a sample of 931 
people who underwent hip or knee joint replacement assessed pre-surgery and at multiple time 
points up to 12 months post-surgery. The findings supported the conclusion that both within and 
across time, pain was associated with activity limitation and activity limitation was associated 
with participation restriction. This was illustrated by a well-fitting SEM identifying standardized 
coefficients among pain, activity limitation and participation after adjusting for age, sex, type of 
surgery, obesity, low back pain, and mood[21]. Another longitudinal study (this one of 548 
patients with knee osteoarthritis) found feedback pathways between the ICF components 
indicating that participation restriction at baseline was predictive or activity limitation 3 years 
later. This same study using CFA and SEM found mental health to be a mediating factor of the 
effect of activity limitation on participation restrictions[22].   
Only a few studies to our knowledge have explored variables associated with pain-related 
disability among people with TMD. Our study was primarily concerned with the relationship 
between physical position of the temporomandibular joint (such as disc displacement) and TMD 
impact. The authors created a model of the relationship between the physical position of the 
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temporomandibular joint and TMD impact, which was a latent variable, measured by: 1) 
observed pain intensity, 2) jaw limitation, and 3) disability. The authors found that these three 
observed variables had strong and precise loadings on the latent TMD impact measure indicating 
pain intensity, indicating the JFLS score and disability points from the GCPS together were a 
useful way to measure impact of TMD. The primary finding was disc displacement is not related 
to TMD impact[26]. This finding suggests the need to look further than physical features to 
understand the impact of TMD pain.  
The second study was a cross-sectional analysis of 399 people with three types of pain 
including myofascial pain syndrome. Participants completed the Multidimensional Pain 
Inventory, the Beck Depression Inventory, and the Minnesota Multiphasic Personality Inventory-
2. These observed variables were used to create latent variables representing pain impact, illness 
conviction, and depression. SEM results supported a causal pathway demonstrating depression 
predicted illness conviction and pain impact[27]. Davis created five measurement models 
(including one for psychological distress) and tested a full SEM with an additional observed 
variable. The results from this cross-sectional study of 251 masticatory muscle pain patients 
included a well-fitting model with significant associations between variables representing 
stressors, psychological distress, arousal, sleep problems, and pain symptoms and no association 
between oral parafunction and pain symptoms[28]. The model published by Davis et al. is shown 
in figure 5.4. In this model, pain-related disability is not measured, but depression, anxiety, and 
affective distress were combined to create a latent variable representing psychological distress 





In the present study, we aimed to empirically investigate the relationship between 
psychological distress, TMD clinical features, and experimental pain sensitivity and pain-related 
disability. Data from a cross-sectional study of people with chronic TMD were analyzed using 
SEM to test the variables that were associated with pain-related disability. Our hypothetical 
model is shown in figure 5.5.  On the left side of this model are indicators of psychological 
distress comprised of four self-reports using standardized instruments, clinical jaw features 
measured by self-reports, and clinical assessments and experimental pain sensitivity assessed by 
four quantitative sensory tests. The right side of the model shows the components of the graded 
chronic pain scale. We hypothesized that pain-related disability would be positively associated 
with increased psychological distress, functional limitation, and experimental pain sensitivity. 
This finding would indicate a strong association between the variables we created based on 
Nagi’s model and pain-related disability (shown in figure 5.6). 
SEM with latent variables accounts for correlated measures measurement error and has 
the benefit of examining multiple relationships simultaneously. Latent variables are useful tools 
to capture the information obtained from observed variables and concurrently account for the 




This cross-sectional study of 1088 people with chronic painful TMD examined the 
relationship between pain-related disability and psychological distress, clinical jaw features, and 
experimental pain features. Data were available from the parent study, the Orofacial Pain: 
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Prospective Evaluation and Risk Assessment (OPPERA) study that was conducted between May 
2006 and October 2013. The OPPERA study included a case-control study that compared 
chronic TMD cases with TMD-free controls. Data for the current study are restricted to the 1088 
chronic TMD cases enrolled in the parent OPPERA study. For more detail about the OPPERA 
study protocol and procedures, see Slade et al., 2011[30]. Human Research Ethics Committees at 
all study sites approved the study protocol. All participants signed an informed consent for study 
participation and were compensated for their time. 
Participants 
Participants were community dwelling individuals with chronic TMD who responded to 
advertisements for people with chronic jaw pain at one of four study sites (University at Buffalo, 
NY; University of Florida Gainesville, FL; University of Maryland in Baltimore, MD; and 
University of North Carolina at Chapel Hill, NC). Participants were aged 18-44 years and were 
required to be fluent in English. Demographic characteristics of the study sample are shown in 
Table 5.2.  
Exclusion criteria were recent facial surgery or facial injury, pregnancy, orthodontic 
procedures, and major medical conditions including kidney disease or uncontrolled 
hypertension[30]. Participants completed a telephone interview to assess eligibility prior to 
completing a battery of questionnaires about health, pain, and psychological functioning and a 3-
hour clinic visit that included clinical examination for verification of TMD and experimental 
pain testing. Chronic TMD was defined as self-reported facial pain symptoms for at least 6 
months prior to enrollment AND fulfillment based on examination criteria described below. The 
6-month threshold is consistent with the definition of chronic pain provided by the Institute of 
Medicine: “Chronic pain, by contrast, lasts more than several months variously defined as 3 to 6 
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months, but certainly longer than “normal healing”[31]. To meet examination criteria for chronic 
TMD, participants had to experience pain in response to either jaw movement or palpation in at 
least 1 of the TMJs or at least 3 masticatory muscles[30]. 
Variables used for SEM 
The measures included a mix of self-reported questionnaire responses, clinical 
measurements of jaw opening and body pain, and experimental pain sensitivity testing results. 
Table 5.3 shows each measurement and instrument included in measurement model creation.  
Pain-related disability 
 The outcome of interest was pain-related disability, which was measured using 
individual items from the Graded Chronic Pain Scale (GCPS). The GCPS contains 7 items to 
assess characteristic pain intensity, interference in daily activities, and disability days (days with 
decreased or impaired functioning). All questions use the past 6 months as the frame of 
reference[32]. Characteristic pain intensity was assessed with three questions using the 0-10 pain 
rating scale. Participants were asked to rate their current pain, worst pain, and average pain over 
the past 6 months. Participants were asked to rate the extent that pain interfered with their daily 
activities, recreation, social and family activities, and work (including housework). The rating 
scale was 0 to 10, where 0 represented “no interference” and 10 was defined as “unable to carry 
on any activities”. Participants were asked two questions about days of interrupted activity. The 
first question asked “approximately how many days in the past 6 months have you been kept 
from your usual activities (work, school or housework) because of facial pain?” The second 
question is not part of the graded chronic pain scale but offers important information about 
“presenteeism” and pain impact. Presenteeism refers to lost of productivity at work or on-the-job 
impairment and is associated with catastrophizing among people with orofacial pain while 
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absenteeism or work missed is associated with pain severity[33]. The question was “How many 
days has your efficiency dropped below 50% of what you consider “normal” for you because of 
facial pain?” using phrasing that referred to all activities and not only job performance. 
Psychological distress 
Psychological distress was measured using positive and negative affect scales from the 
Profile of Mood States-Bipolar (POMS-Bi)[34], somatization subscale from the Symptoms 
Checklist 90-Revised (SCL-90R)[35], and the catastrophizing subscale of the Coping Strategies 
Questionnaire (CSQ-R)[36].  
Clinical TMD features  
These were assessed using measured jaw opening, number of painful body sites, oral 
parafunctional behaviors, jaw functional limitation, number of comorbid conditions, and duration 
of TMD pain. Instructions for the measured jaw opening measurement was “Open as wide as you 
can even if you feel pain or increase any pain you are feeling” and opening distance was 
measured in millimeters. The number of painful body sites was measured by applying pressure to 
7 sites bilaterally including the trapezius, supraspinatus, second rib, lateral epicondyle, medial 
gluteus, greater trochanter, and medial knee[37]. The respondent reported pain or no pain at each 
site for a sum score from 0-14. Oral parafunctional behavior was measured with the Oral 
Behavior Checklist (OBC) summary score[38]. The Jaw Functional Limitation Scale (JFLS) 
measured limitations in three areas: chewing limitation, opening limitation, and verbal or 
emotional expression[39]. Comorbid conditions were assessed by asking participants a question 
about the presence or absence of 20 conditions: joint disease or arthritis, fibromyalgia, chronic 
fatigue syndrome, irritable bowel syndrome, tendency to faint, ringing in ears, periodic heart 
racing or pounding, repeated trouble with neck, back, or spine, insomnia, depression, panic 
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disorder, post-traumatic stress disorder, anxiety disorder, acid reflux, interstitial cystitis, 
prostatitis, multiple chemical sensitivity, dysmenorrhea, chronic pelvic pain, and sleep apnea. 
We used a sum score ranging from 0-20 corresponding to the number of conditions endorsed by 
participants. We assessed TMD pain duration through self-reports of when their facial pain 
began.  
Experimental pain sensitivity  
Experimental pain sensitivity included measures of thermal tolerance, mechanical pain rating of 
a flat-tipped probe, temporal summation of mechanical probe, and pressure pain thresholds 
evaluated at the trapezius muscle. Full details of experimental testing procedures are described in 
Greenspan, 2011[40]. 
Statistical analysis 
Completeness of data, mean, minimum, and maximum variables were analyzed and are 
shown in Table 5.4. All analyses were performed using the Mplus software, version 8.0[41]. 
After generating univariate statistics to summarize the data, we conducted three separate 
analyses. First, we re-validated the GCPS with the inclusion of the question asking about 
decreased efficiency. Second, we performed confirmatory factor analysis (CFA) to create latent 
variables representing: 1) psychological distress, 2) clinical TMD features, and 3) experimental 
pain sensitivity. Finally, we performed a full SEM to examine the relationships between the three 
latent variables we created and the variable representing pain-related disability.  
Structural equation modeling 
Robust maximum likelihood was used to address non-normality of variable distribution. 
Models were evaluated first by assessing parameter estimates and subsequent elimination of 
variables with low parameter estimates. Then model fit was evaluated based on established 
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guidelines for goodness of model fit described below. Model fit was assessed using two absolute 
fit indices: Chi-square test of model fit and root mean square error of approximation (RMSEA). 
The RMSEA tells us how well the model, with unknown but optimally chosen parameter 
estimates, would fit the population’s covariance matrix. Incremental fit indices included the 
comparative fit index (CFI) and Tucker-Lewis Index (TLI), both of which account for sample 
size and performance of the model[42]. Criteria for the model fitness was based on established 
values for fit indices: CFI/TLI values > 0.95, an RMSEA <0.07[43]. After verifying the fit of 
each CFA, we built a full structural equation model and performed post-hoc exploratory analysis 
to improve the fit based on the above criteria for goodness of fit. Variables were eliminated from 
models where standardized parameter estimates were low (less than 0.3) or when the 
standardized parameter estimates were not statistically significant (p>0.05). Variable removal 
was performed individually and exploratory analysis continued with deleting variables from the 
model until the model demonstrated good fit. Code of the SEM analyses is reported in the 
Supplementary Material section. 
Re-validating the GCPS: assessing pain-related disability 
In order to determine validity with the observed variable assessing presenteeism, we 
needed to compare the model without with variable and a model that includes the presenteeism. 
We compared two first-order models: one with the 7 traditionally used GCPS items and a second 
model including the variable measuring presenteeism. This is simplistic because ideally, the 
GCPS is a second-order confirmatory factor analysis but with only the one variable representing 
participation, we are unable to create a latent concept for participation based on multiple 
observed variables. Based on that result, we inspected parameter estimates and goodness of fit 
statistics to determine the validity of the inclusion of the presenteeism variable. If the fit statistics 
 89 
did not reflect a poorer fitting model, then based on the theoretical framework and conceptual 
model, we proceeded to validate a second-order confirmatory factor analysis (CFA) of the GCPS 
with latent variables for pain intensity, interference, and participation. A second-order CFA is 
distinguished from a first-order in that the second-order CFA involves creation of latent variables 
comprising another latent variable. For illustration see figure 5.7. 
We performed second-order confirmatory factor analysis (CFA) based on the established 
structure of the GCPS with an additional variable loading on the “participation” latent variable. 
The latent variable of pain-related disability was comprised of three contributing latent 
constructs: characteristic pain intensity, pain interference, and participation. The characteristic 
pain intensity latent variable was expressed by three factors: average, current, and worst facial 
pain. The interference latent variable was comprised of interference in daily, social and work 
activities. The participation latent construct was operationalized using number of days of work 
missed and number of days efficiency dropped below 50% due to pain. 
Measurement models 
Clinical pain features 
We started with a model that included the following eight observed variables: the JFLS 
chewing limitation score, JFLS opening limitation score, JFLS expression limitation score, 
maximum unassisted jaw opening from the clinical examination, count of 20 common comorbid 
conditions, self-reported duration of pain, OBC sum score, number of painful body sites.  
Psychological distress 
We began with a model that included the following four observed variables: 1) the 
catastrophizing subscale, 2) the somatization scale, 3) positive and 4) negative affect scales.  
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Experimental pain sensitivity 
We built a model using the latent variable experimental pain sensitivity with the factors 
of heat pain tolerance, pressure pain threshold, mechanical pain rating, and mechanical temporal 
summation.  
Full SEM 
To explore the relationships between the latent constructs of clinical pain features, 
psychological distress, experimental pain sensitivity, and pain-related disability we built a full 
SEM regressing the validated measurement models of pain-related disability onto the models 
described above. We also regressed sex, age, study site, and race onto pain-related disability 
based on previous research about both pain-related disability and pain severity. The model was 
evaluated based on parameter estimates and model fit indices described above. Exploratory 
changes to the model were based on parameter estimates as described above. Modification 
indices calculated by Mplus indicated when model fit could be improved by accounting for 
correlation among variables. Additionally, we restricted the sample by sex and re-ran the final 




The mean age among participants was 29.2 years (7.8 SD) with a mean duration of pain 
of 6.9 years (6.4 SD). 70% of participants were white and 76% of participants were female. 
There were more people enrolled at the Chapel Hill study site; the Baltimore study site enrolled 
the fewest participants. Table 5.2 shows characteristics of the study sample. Table 5.4 lists each 
latent variable with the observed variables, the number of participants with complete data for 
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each variable, and the mean, minimum, and maximum values for each variable. Demographic 
data were collected upon entry: age, self-reported sex, self-identified racial identity, and study 
site. Demographic variables were control variables regressed onto the outcome variable to 
account for demographic and study site influences on the outcome. Participants rated their 
current facial pain at a mean of 3.8 (2.5 SD) using the 0 to 10 scale, while the mean worst facial 
pain in the past 6 months was 7.5 (2.0 SD). The “disability days” variables had a non-normal 
distribution with 50% of the sample reporting they did not experience any days when they were 
kept from their usual activities because of facial pain. Reduced efficiency was more common 
with 25% of the sample reporting 35 or more days during which their efficiency dropped below 
50% of what they considered to be normal.  
Exploratory modeling results 
Results from the measurement models of pain-related disability with and without the 
variable measuring presenteeism were compared. The first-order 7 variable model had poor fit 
(RMSEA=0.219, 90% CI for RMSEA (0.206, 0.233), CFI =0.749, TLI=0.624, SRMR=0.108). 
The first-order model with 8 variables demonstrated slightly better fit (RMSEA=0.192, 90% CI 
for RMSEA (0.181, 0.204), CFI =0.752, TLI=0.653, SRMR=0.105) than the model without the 
presenteeism variable.  
This result from the 8 variable model justified the creation of the second-order 
confirmatory factor analysis (see figure 5.8). The standardized parameters show the highest 
contribution from the interference latent variable (0.88), the participation latent variable had a 
high loading (0.83) and the pain intensity latent variable was strong and significant but a lower 
value (0.65) than the other two latent constructs. This re-validated GCPS model demonstrated 
excellent fit (Chi2= 62 (p<0.0001), df=17, RMSEA=0.050, 90% CI for RMSEA (0.037, 0.063), 
 92 
CFI =0.986, TLI=0.977, SRMR=0.021). These results supported the validity of this revised 
GCPS model.  
Measurement models 
The full measurement model based on our hypothesized model assessing TMD clinical 
features demonstrated a poor fit. Subsequently, variables were eliminated from the model when 
standardized parameter estimates were less than 0.03 (comorbid conditions, duration of pain and 
OBC score) or did not have a p-value supporting a significant contribution to fit (number of body 
sites reporting pain).  
The model building process with model fit indices and parameter estimates are shown in 
tables 5.5 and 5.6 respectively. The measurement model of clinical TMD features was reduced to 
a simplified model containing 3 variables: JFLS subscores measuring opening, chewing, and 
expression limitation. The measurement model representing psychological distress demonstrated 
adequate fit after accounting for correlation between the positive and negative affect scales. 
The model fit for the experimental pain sensitivity latent variable was good. All factors 
met statistical significance criteria. The factor loading reflected a positive relationship for heat 
pain tolerance and pressure pain threshold and a negative relationship for mechanical pain rating 
and mechanical temporal summation. The well-fitting finalized measurement model containing 
all three latent variables (clinical TMD features, psychological distress, and experimental pain 
sensitivity) is shown in figure 5.9. 
A four-factor model was proposed to measure psychological distress defined by the 
following indicators: somatization, catastrophizing, positive and negative affect. The fit of this 
model was improved after the removal of the positive affect variable. An eight-factor model was 
proposed to measure clinical TMD features using the following indicators: opening limitation, 
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chewing limitation, expressional limitation (all from the JFLS), the OBC sum score, 
measurement of jaw opening, number of painful body sites, and duration of pain. Duration, 
number of comorbid conditions, OBC score, jaw opening, and number of painful body sites did 
not load well (standardized parameter estimates less than 0.3) on the latent factor. We 
systematically removed these variables one at a time in an exploratory process that resulted in a 
reduced three-factor model restricted to the three subscales from the JFLS. Fit indices for the 
final exploratory measurement model demonstrated very good fit shown in figure 5.9 (Chi2= 93 
(p<0.0001), df= 30, RMSEA= 0.044, 90% CI for RMSEA (0.034, 0.054), CFI = 0.969, TLI= 
0.953, SRMR = 0.036).  
Structural relationships 
The above measurement model result met the criteria specified in the methods section for 
goodness of fit, permitting the next step of building the full structural equation model. Based on 
the measurement model results, we proceeded to fit a SEM of pain-related disability regressed 
onto latent variables representing psychological distress, jaw pain features, and experimental 
pain sensitivity. Table 5.7 outlines the model-fitting process and the respective fit indices for 
each alternative model. The initial full model had moderate fit indices indicating improvements 
in the model specification might improve the fit of the model. To explore and improve fit, we 
first removed the experimental pain sensitivity latent variable because the standardized 
parameter estimate (although statistically significant p<0.000) was weakly associated with pain-
related disability (estimate=-0.171).  
Next, we removed observed variables with standardized estimates <0.6: negative affect, 
positive affect, and maximum jaw opening. The standardized parameter estimates for each step 
in the exploratory model-building process are shown in table 5.8. Based on the modification 
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indices, we added acknowledgement of correlation between the latent variables for participation 
and interference. This adjustment is consistent with the guiding conceptual model for the 
concepts of jaw functional limitation and pain-related disability. These changes resulted in the 
final model, which is shown in figure 5.10. The final model demonstrated good fit (fit indices: 
Chi2= 415 (p<0.0001), df= 119, RMSEA= 0.048, 90% CI for RMSEA (0.043, 0.053), CFI= 
0.956, TLI= 0.946, SRMR= 0.040) and explained 78% of the variance in pain-related disability.  
We controlled for study site, sex, age, and race in the full model. The control variables 
were used to account for study design and demographic differences in pain-related disability. 
Jaw limitation and psychological distress had strong loadings on the latent pain-related disability 
variable (.41 and .58 respectively). Parameter estimate, standardized estimates and p-values for 
all variables in the final model are shown in table 5.9.  
Finally, we ran the final model stratified by sex to examine the potential impact of sex on 
the whole model. The model fit was good for both men and women and the latent variable 
loadings were similar. The only difference in significance was that age was not significant in the 
model restricted to men while age was a statistically significant predictor of pain-related 
disability although the parameter estimate was low. For both analyses, the psychological distress 
latent variable had an increased relationship with pain-related disability compared to the jaw 
functional limitation variable but this relationship was stronger in the analysis restricted to males 
only (results not shown).  
4 Discussion 
Key Results 
Our results show jaw features and psychological distress have a strong impact on pain-
related disability. Psychological distress and jaw functional limitation were both positively 
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associated with disability. As psychological distress measured by somatization and 
catastrophizing variables increased, pain-related disability increased. Psychological distress 
accounted for a higher amount of variance in pain-related disability compared to jaw limitation. 
In the exploratory model-building process, exclusion of the latent construct measuring 
experimental pain sensitivity due to low factor loading supports the conclusion that pain testing 
does not contribute to pain-related disability.    
Control variables demonstrated that age, study site, and race were statistically significant 
predictors of pain-related disability but the parameter estimates for these variables were very low 
indicating small influence. Control variable parameter estimates were in the expected direction 
indicating as age increased, pain-related disability increased. Sex was the only sociodemographic 
variable that was not statistically significantly associated with pain-related disability.  
Because controlling for sociodemographic variables on the main outcome variable does 
not account for potential sociodemographic differences in the latent variables, we performed 
stratification by sex. When the model was stratified by sex, women compared to men 
demonstrated similar results, indicating no sex differences among participants in pain-related 
disability. If there were differences between men and women in the observed variables 
measuring psychological distress and TMD clinical features, then we would have observed 
changes in parameter estimates and overall goodness of fit of the models. 
Limitations  
The primary limitation of this study is the cross-sectional design. In this cross-sectional 
analysis it is impossible to draw conclusions about causality because there is no temporal 
component. The SEM approach assumes causality by the use of one-way arrows between 
exogenous and endogenous variables. When selecting variables to identify in regression models, 
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we impose a casual structure on the data. There is a need for future research to validate the 
model reported here in a longitudinal setting.  
SEM has multiple strengths that made it the optimal choice for this analysis. SEM 
permits complex continuous outcome variables, accounts for correlated variables, measurement 
error, handles missing data well, and performs simultaneous examination of multiple 
relationships between variables. However, SEM requires strong assumptions that cannot be 
overlooked. These include the assumption of linear relationships between variables and the 
assumption of no unmeasured confounding. In this study, there is the possibility that an 
unmeasured variable caused psychological distress, jaw limitation, and pain-related disability. 
These assumptions have been cited as a reason for caution when using SEM, particularly the 
recommendation that SEM is best used when there are many effects being explored for 
hypothesis generation[44]. 
Interpretation 
As catastrophizing, somatic symptoms, and jaw limitations increased, pain-related 
disability increased. We can conclude several variables examined did not contribute to pain-
related disability. Experimental pain sensitivity, several clinical jaw features including oral 
parafunction behavior, pain duration, number of comorbid conditions, and the number of painful 
body sites were all excluded from the model to improve fit. This demonstrates the lack of 
relationship between the variables listed above and pain-related disability.  
Catastrophizing loaded slightly higher than somatization on the psychological distress 
latent variable indicating that the impact of catastrophizing may be very important in 
understanding the construct of pain-related disability.  This is consistent with previous research 
about the association between catastrophizing and TMD pain[14, 45-48]. In a cross-sectional 
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study of a rural chronic pain population, pain catastrophizing was reportedly associated with pain 
intensity, interference and perceived disability and was found to be associated with perceived 
disability after controlling for demographics and depression, while depression was associated 
with pain interference and life satisfaction[49]. Our findings from urban and suburban study sites 
support the importance of pain catastrophizing consistent with the above finding.  
Both psychological distress and functional limitation have been found to be associated 
with high pain-related disability[18, 20, 50]. This work is the first to model experimental pain 
sensitivity as a latent construct and examine the relationship between experimental pain 
sensitivity and pain-related disability. The inclusion of experimental pain sensitivity was based 
on the biopsychosocial model of pain[51] and the hypothesis that experimental pain testing may 
measure biological processes such as central sensitization that underlie chronic painful TMD. 
Research identified somatosensory amplification (increased perception of normal sensation as 
intensity and/or distressing) among women with chronic orofacial pain[52]. Somatosensory 
amplification is thought to be a feature common among many pain conditions including 
fibromyalgia and also among several psychiatric conditions such as anxiety[53]. Although 
people with TMD have lower pain pressure thresholds[54] and thermal tolerance[55] when 
compared to pain-free individuals, our finding supports the conclusion that experimental pain 
sensitivity is not associated with pain-related disability.  
Generalizability 
Strengths of the study include the large sample size of community dwelling participants 
with chronic painful TMD. The sample size and recruitment of people from surrounding 
communities as opposed to specialty pain clinics supports the generalizability of findings to 
people with chronic painful TMD.  
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A study of pain-related disability among people with chronic pain conditions including 
low back pain[56] utilized SEM to model relationships between factors related to disability.  
Among 156 patients with low back pain, predictors of increased disability included female sex, 
depression, and fear avoidance beliefs while fulltime employment predicted decreased 
disability[56]. Our finding contrasts this finding that sex was associated with disability but 
supports the conclusion that increased depression (measured as negative affect in this study) is 
associated with increased disability. We did not include assessment of employment status in this 
study.  
Conclusion 
We specified and estimated a model based on theory and previous literature to examine 
factors potentially associated with pain-related disability. This model included latent constructs 
measuring psychological distress, jaw functional limitation, experimental pain sensitivity, and 
pain-related disability. We started with a full model and performed modifications based on 
parameter estimates and model fit indices in order to improve model fit.  
The results of this cross-sectional study of people with chronic TMD suggest somatic 
symptoms, catastrophizing, and jaw functional limitations are important factors to assess in order 
to understand pain-related disability. Results also demonstrate that experimental pain sensitivity, 
jaw opening, positive and negative affect scores, duration of pain, and oral parafunction 
behaviors are not relevant to pain-related disability.  After removing the latent construct of 
experimental pain sensitivity, we simplified the model retaining latent variables measuring 
psychological distress and jaw functional limitation.  
Future research may consider each individual latent structure comprising the GCPS to 
determine if model fit can be improved upon using individual component of the GCPS. For 
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example, variables may be more likely to be associated with pain intensity but not interference or 
vice versa. Future studies should explore this model in other pain populations such as 
fibromyalgia and migraine headache to explore commonalities and differences among pain 
populations. The measures in the final model were culled from self-reported instruments making 
collection of this information straightforward and requiring minimal time or participant burden.  
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Table 5.1. Definitions of concepts used in WHO and Locker models 
 
 adapted from Locker 1992 and WHO 
Concept Definition 
Impairment  
1988 Anatomical loss, structural abnormality or disturbance in biochemical or 
physiological proceesses which arises as a result of disease or injury or is present at 
birth 




1988 Restrictions in the functions customarily expected of the body or its component 
organs or systems 
2001 Functioning refers to all body functions, activities and participation 
Disability  
1988 Any limitation in or lack of ability to perform the activities of daily living 
2001 An umbrella term for impairments, activity limitations and participation restrictions 
Handicap  
1988 The disadvantage and deprivation experienced by people with impairments, 
functional limiations, pain and discomfort or disabilities because they cannot or do 







Table 5.2. Demographic profile of study participants (n=1088) 
 
Variable N Percent 
Race   White 765 70.3 
Black 175 16.1 
Asian 45 4.1 
Other 103 9.5 
Sex   
Female 835 76.8 
Male 253 23.2 
Study Site   UNC 342 31.4 
UB 247 22.7 
UFL 271 24.9 
UMD 228 21.0 
UNC= University of North Carolina at Chapel Hill; UB=University of Buffalo, NY; UFL=University of Florida at 








Latent variable name Observed variable Instrument Citation  
Psychological distress Somatization  SCL_90R Somatization 
scale 
Derogatis[35] 
 Catastrophizing  Coping strategies 
questionnaire  
Rosenstiel[36] 
 Positive & negative affect scores  Profile of mood states-
Bipolar 
Lorr[57] 
Clinical TMD features Maximum unassisted opening 
(mm) 
Jaw mobility examination Ohrbach[37] 




 Oral parafunction behavior  Oral behaviors checklist Markiewicz[38] 
 Chewing, opening, and 
expression limitation scores 
Jaw functional limitation 
scale 
Ohrbach[39] 
 Count of comorbid pain 
conditions & duration of pain  





Thermal tolerance, pressure pain 
threshold, mechanical probe 





Pain-related disability Characteristic pain intensity, 
interference, and disability 
Graded Chronic Pain 
Scale 
Von Korff[32] 
  Days efficiency dropped below 
50% due to facial pain  
Single-item question Ohrbach[37] 










name Observed variable N  Mean Min Max 
PD Psychological distress Somatization scale  1073 0.7 0.0 3.1 
  Catastrophizing scale 1079 1.5 0.0 6.0 
  Positive affect score  1082 80.3 35.0 118.0 
  Negative affect score  1082 58.6 30.0 111.0 
TMD Clinical TMD features Maximum unassisted opening 1069 46.7 8.0 78.0 
  Number of painful body sites 1074 6.0 0.0 14.0 
  Oral behaviors checklist sum 1079 33 0.0 84.0 
  JFLS chewing score 1069 2.5 0.0 10.0 
  JFLS opening score 1069 2.7 0.0 10.0 
  JFLS expression score 1069 1.2 0.0 10.0 
  
Count of comorbid pain 
conditions 1055 2.7 0.0 20.0 
  Duration of pain (years) 1070 6.9 0.0 35.0 
EXP Experimental pain sensitivity Thermal tolerance (
o Celsius) 1013 45.4 33.5 51.5 
  
Pressure pain threshold Trapezius 
(kPa) 1013 277.6 101.6 600.0 
  Mechanical probe pain rating  1047 12.0 0.0 94.8 
  
Mechanical windup (change in 
pain rating) 1047 13.3 -13.7 85.0 
PRD Pain-related disability      
CPI Characteristic pain intensity Current pain intensity  1062 3.8 0.0 10.0 
  Average pain intensity 1062 5.4 0.0 10.0 
  Worst pain intensity 1062 7.5 0.0 10.0 INTER Pain interference Interference in daily activities 1062 2.5 0.0 10.0 
  Interference in social activities 1062 2.4 0.0 10.0 
  Interference in work activities 1063 2.2 0.0 10.0 
PAR  Participation Days kept from activities due to facial pain  1054 17.5 0.0 360.0 
kPA= kilopascals     
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Table 5.5. Description and fit indices for measurement models of psychological distress, clinical 
TMD features, and experimental pain sensitivity 
 




p-value RMSEA (90% 
CI) 
CFI TLI SRMR 
Model 
1 
Full model 1088 1246 
(101) 
1.077 <0.001 0.102 
(0.097, 0.107) 








1.058 <0.001 0.078 
(0.070,0.086) 











1.105 <0.001 0.062  
(0.053, 0.071) 
0.934 0.907 0.051 
RMSEA= root mean squared error approximation; CFI= comparative fit index; TLI=Tucker Lewis index; 






Table 5.6. Standardized parameter estimates from 3 models starting with the full model and then 
performing exploratory model alterations to obtain the best-fitting model 
 
 Model 1 Model 2 Model 3 
Psychological Distress    
Somatic symptoms 0.673 0.660 0.793 
Catastrophizing 0.568 0.550 0.608 
Positive affect -0.585 -0.595  
Negative affect 0.768 -0.783 0.615 
Clinical TMD features    
Chewing limitation 0.772 0.771 0.773 
Opening limitation 0.878 0.887 0.882 
Expression limitation 0.721 0.716 0.722 
Jaw opening -0.353   
Number of painful body sites 0.082   
Oral behavior checklist sum 0.213   
Duration of pain 0.082   
Number of comorbidities 0.253   
Experimental pain sensitivity    
Thermal threshold 0.550 0.548 0.542 
Pressure pain threshold 0.418 0.413 0.413 
Mechanical pain rating -0.508 -0.512 -0.517 




Table 5.7. Description and fit indices for 3 models of pain-related disability, clinical TMD 
features, psychological distress, and experimental pain sensitivity 
 








CFI TLI SRMR 
Model 1 Full model 1088 833  
(193) 
1.095 <0.001 0.055  
(0.051, 0.059) 
0.913 0.898 0.057 
Model 2 Dropped 
EXP 
1085 559  
(122) 
1.080 <0.001 0.057  
(0.053, 0.062) 
0.935 0.922 0.055 
Model 3 Added 
correlation 
1085 415  
(119) 
1.081 <0.001 0.048  
(0.043, 0.053) 
0.956 0.946 0.040 
df= degrees of freedom; RMSEA= root mean squared error approximation; CFI= comparative fit index; TLI=Tucker 






Table 5.8. Standardized parameter estimates from 3 models starting with the full model and then 
performing exploratory model alterations to obtain the best-fitting model 
 
 Model 1 Model 2 Model 3 
Characteristic pain intensity 0.708 0.706 0.814 
Current 0.713 0.712 0.771 
Average 0.871 0.871 0.791 
Worst 0.779 0.778 0.683 
Interference 0.849 0.851 0.734 
Daily 0.883 0.883 0.882 
Social 0.907 0.907 0.907 
Work 0.904 0.903 0.903 
Participation 0.807 0.805 0.689 
Days kept from activity 0.741 0.741 0.741 
Days less efficient 0.877 0.875 0.875 
Clinical TMD features    
Chewing limitation 0.621 0.619 0.643 
Opening limitation 0.716 0.714 0.733 
Expression limitation 0.883 0.886 0.859 
Psychological distress    
Somatic symptoms 0.736 0.736 0.619 
Catastrophizing 0.688 0.688 0.734 
Negative affect 0.574 0.574 0.421 
Experimental pain sensitivity    
Thermal threshold 0.536   
Pressure pain threshold 0.414   
Mechanical pain rating -0.521   
Mechanical temporal summation -0.456   
Structural model    
PD!PRD 0.425 0.459 0.578 
TMD!PRD 0.388 0.418 0.406 
EXP!PRD -0.199   
Age!PRD 0.117 0.110 0.131 
Study site!PRD 0.098 0.096 0.124 
Race!PRD 0.030 0.059 0.059 
Sex! PRD -0.049 -0.009 0.007 





Table 5.9. Structural equation model results: association of pain-related disability, psychological 








Characteristic pain intensity 0.814 0.029 <0.001 
Current 0.771 0.021 <0.001 
Average 0.791 0.022 <0.001 
Worst 0.683 0.023 <0.001 
Interference 0.734 0.029 <0.001 
Daily 0.882 0.014 <0.001 
Social 0.907 0.011 <0.001 
Work 0.903 0.012 <0.001 
Participation 0.689 0.034 <0.001 
Days kept from activities 0.741 0.032 <0.001 
Days with reduced efficiency 0.875 0.025 <0.001 
TMD clinical features   
Chewing limitation 0.643 0.031 <0.001 
Opening limitation 0.733 0.025 <0.001 
Expression limitation 0.859 0.024 <0.001 
Psychological distress   
Somatic symptoms 0.618 0.033 <0.001 
Catastrophizing 0.764 0.034 <0.001 
Negative affect 0.421 0.037 <0.001 
Structural model   
Psychological distress!PRD 0.578 0.054 <0.001 
Clinical TMD features!PRD 0.406 0.053 <0.001 
Age!PRD 0.133 0.030 <0.001 
Study site!PRD 0.124 0.031 <0.001 
Race!PRD 0.059 0.027 0.030 
Sex!PRD 0.007 0.030 0.801 
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Figure 5.5. Hypothesized model of pain-related disability and constructs contributing to pain 
related disability 
 
Latent variables are represented by circles while observed variables are shown as rectangles. 
Arrows from latent variables onto observed variables represent the variables used to create the 















Figure 5.7. Structure of the second-order confirmatory analysis with latent variables denoting 
pain intensity, interference, and participation.  




































Figure 5.8. Re-validated structure of the Graded Chronic Pain Scale (GCPS) with the addition of 

















Figure 5.10. Final model and standardized parameter estimates of pain-related disability, 
psychological distress, and TMD clinical features.  
Latent variables are shown in circles while observed variables are in rectangles. Control 
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CPI INT DIS PRD JFLS PD Age 
CPI   
      INT 0.598*  
     PAR 0.561* 0.718*  
    PRD 0.814* 0.734* 0.689*  
   JFLS 0.574* 0.518* 0.485* 0.705*  
  PD 0.641* 0.579* 0.543* 0.788* 0.517*  
 Age 0.116* 0.105* 0.098* 0.143* 0.000 0.000  
Note: CPI=Characteristic pain intensity, INT=Interference, PAR=Participation, 
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CHAPTER SIX: SYNTHESIS 
In this project I examined pain-related disability among people with chronic orofacial 
pain using two different approaches. The first approach determined characteristics associated 
with high pain-related disability using a binary logistic regression model to discriminate between 
people with low or high pain-related disability. The second approach explored the relationships 
between psychological distress, TMD clinical features, experimental pain sensitivity and pain-
related disability using structural equation modeling. I hypothesized that increased psychological 
distress (including negative affect, somatization, and catastrophizing) and clinical features of 
TMD (such as as jaw limitation, oral behaviors, and pain upon palpation) along with greater 
sensitivity to experimental pain (reduced thermal pain tolerance and pressure pain thresholds, 
increased mechanical pain ratings) would be associated with increased pain-related disability.  
The broader goal was to provide insight into factors associated with pain-related disability for the 
purposes of increasing understanding the quality of life among people with chronic orofacial 
pain. Insight into these characteristics could help clinicians determine the risk of disability 
among patients with TMD, provide a template for exploring pain-related disability in other 
chronic pain conditions such as low back pain, and suggest targets for intervention to reduce 
disability. 
Pain-related disability 
Pain-related disability was assessed using the Graded Chronic Pain Scale (GCPS), which 
includes individual items addressing pain intensity, pain interference, and days kept from usual 
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activities. Each question is anchored to the previous 6 months. There is not an existing gold 
standard measure for evaluating pain-related disability, but the GCPS has been used in several 
chronic pain populations including TMD and we believe this to be a comprehensive measure of 
the impact of pain on the individual particularly with the addition of the variable measuring 
presenteeism. The latter conclusion was supported by findings that the addition of a variable 
measuring presenteeism as “how many days has your efficiency dropped below 50% of what you 
consider ‘normal’ for you because of facial pain?” increased the fit of a model of pain-related 
disability using the GCPS with and without the presenteeism variable (see further details below). 
Predicting High Pain-related Disability: Summary of Findings 
Aim one asked the question “how can we discriminate between people with low vs. high 
pain-related disability?” The results demonstrated that people with high pain-related disability 
had greater jaw functional limitation, more widespread body pain, and higher levels of 
catastrophizing compared to people with low pain-related disability. In contrast, experimental 
pain sensitivity, jaw opening, gender, and duration of pain did not increase the ability to 
discriminate level of disability. I created a final parsimonious model that included 
sociodemographic variables (age, sex, study site, and race/ethnicity) and the summary score from 
the Jaw Functional Limitation Scale, the catastrophizing subscale from the Coping Strategies 
Questionnaire, and the number of body sites reported as painful upon palpation during the 
clinical examination. This final model had a cross-validated AUC of 0.79, which was as good as 
the full model containing all variables, indicating good ability to discriminate between the two 
groups. The results cast light on the study’s broader goals by identifying three features that can 
be used to identify treatment targets that are likely to influence the outcome of reduced pain-
related disability. 
 125 
Exploring Relationships Between Psychological, Clinical, and Experimental Measures and 
Pain-Related Disability: Summary of Findings 
 
There were 3 major results in the work addressing aim 2. First, the good fit of the model 
of pain-related disability using the GCPS with the additional variable assessing presenteeism. 
Presenteeism was measured with the question “How many days has your efficiency dropped 
below 50% of what you consider normal?’. This question was combined with the variable 
assessing the number of days people were kept from activities and loaded onto a latent variable 
labeled “Participation”. The resulting model demonstrated better fit than the model without the 
presenteeism variable. This finding supports the conclusion that among people with TMD, 
measuring presenteeism is a useful addition to the standard GCPS items. Second, measurement 
models for the constructs of interest: psychological distress, TMD clinical features, and 
experimental pain sensitivity were created and well fitting. Finally, the above results were 
combined in a full structural equation model. I developed a model involving regression of the 
latent variable measuring pain-related disability onto the two latent constructs that represented 
psychological distress (observed variables were negative affect, somatic symptoms, and 
catastrophizing) and TMD clinical features (based on observed variables from the JFLS 
measuring chewing limitation, opening and expression limitation). The model explained 78% of 
the variance in pain-related disability. The results indicated that increased psychological distress 
and increased jaw limitation were associated with increases in pain-related disability. The 
experimental pain sensitivity latent variable was dropped from analysis due to low parameter 
estimates that indicated a weak relationship between experimental pain sensitivity and disability. 
The results cast light on the study’s broader goals by showing that jaw limitation, negative affect, 
somatic symptoms, and catastrophizing explain a large amount of variance in pain-related 
disability while experimental pain sensitivity did not.  
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Clinical and Public Health Significance 
Several of our findings have significance for public health and how to address the burden 
of chronic pain. We found 33% of the community-dwelling study sample met criteria for high 
pain-related disability. This frequency of disability is concerning considering that one in twenty 
people in the general population have TMD symptoms and that high pain-related disability is 
associated with greater healthcare costs.[1]. The Institute of Medicine’s report titled “Relieving 
Pain in America” includes people with TMD among the millions of Americans living with 
chronic pain[2].  
The key result from both studies is that psychological distress and jaw functional 
limitation are associated with high pain-related disability among people with chronic orofacial 
pain. The clinical and public health implications of this finding underscore a need for assessment 
of both psychological distress and jaw limitation in TMD patients. This finding also supports a 
more comprehensive approach to the treatment of TMD, one that goes beyond the jaw and 
recognizes the whole person. 
Psychological distress can be identified by self-report via questionnaires and can be 
targeted for intervention using cognitive behavior therapy (CBT) or biofeedback[3-5]. Research 
has shown a decrease in pain-related disability at least in the short term after CBT and 
biofeedback interventions. Jaw functional limitation can be assessed in a 10-minute self-report 
questionnaire, and may be targeted with physical therapy to increase an individual’s ability to 
open and chew[6, 7] and increase physical activity[8] to reduce pain-related disability. 
Interestingly, we found that sex and pain duration were not associated with disability, 
conflicting with previous research that indicated women were more likely to experience pain-
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related disability. Our finding suggests that disability is as common among men as women while 
women are still more likely to suffer from chronic TMD.   
Experimental pain sensitivity was assessed as a measure of underlying biological pathology (a 
construct in Nagi’s model of disability) and not found to be associated with pain-related 
disability. Based on this finding, we can conclude that experimental pain sensitivity is not an 
adequate marker of biological pathology. We should not rule out the presence of an underlying 
biological pathology contributing to pain-related disability, but instead focus on the more 
proximal causes such as pain coping strategies and psychological dysfunction. 
Conclusions 
Findings from the two approaches had more commonalities than differences. Both 
approaches identified jaw functional limitation, somatic symptoms, and catastrophizing as key 
contributors to pain-related disability. After accounting for those measures, experimental pain 
sensitivity did not meaningfully contribute further to pain-related disability, a result that was 
seen using both approaches.  Likewise, results from both studies indicated neither gender nor 
duration of pain symptoms contributed additionally to pain-related disability, a finding that 
contradicts previous research. I think this means high impact is the result of individual level 
psychological and social conditions and less likely to be rooted in biological or hormonal causes. 
These results are relevant to the study’s broader goals of assessing the importance of factors 
(including established risk factors for pain onset or pain severity) to understanding the impact of 
pain. 
However, the two approaches revealed some important differences in the types of factors 
that, on the one hand discriminate between high- and low-disability, and on the other hand, 
explain relationships among correlates of disability. For example, using SEM, the number of 
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body pain sites displayed poor model fit and hence was not retained in the final model whereas 
this variable was useful in discriminating between low and high pain-related disability in the 
results of aim one. This could mean the number of body sites is not predictive of pain impact or 
it may point to an error in methodology. I hypothesized painful sites would load onto the variable 
representing TMD clinical features but upon further consideration I think whole body pain may 
be a separate construct deserving it’s own measurement. I am hesitant to disregard the 
importance of body pain sites for two reasons: 1) the established relationship between 
psychological distress and body pain and 2) the discriminatory importance of number of pain 
sites found in the aim one results. Likewise, somatization score was not included in the final 
model addressing aim one because somatization did not contribute to a difference in the AUC, 
but somatization was included in the conceptual model tested in aim two and shown to 
significantly load onto the psychological distress variable. These differences in findings revealed 
by the two approaches are not easy to explain. I interpret these discrepancies in part due to the 
nature of the methods used and potential relationship between somatic symptoms and widespread 
body pain measured by palpation of body sites.  The logistic model used to address aim 1 
involved each variable controlled for the other variables in the model whereas the SEM approach 
did not involve adjustment for other variables but accounted for measurement error.  
It is important to note the limitation of the cross-sectional setting for drawing conclusions 
about causality between these factors identified and increased pain-related disability. Without 
following people over time to measure the incidence of pain-related disability it is not possible to 
draw substantial conclusions about the causes or risk factors of disability.  
The use of cross-sectional data proved necessary for testing our theoretical model of 
existing pain-related disability to utilize a large sample size for exploration of a variety of 
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variables. Examining the experience of people who had been living with chronic pain for 
multiple years and have had time to develop coping strategies and experience the impact of their 
condition on their work, social, and family obligations, permitted the conclusion that 
psychological distress and jaw functional limitation are key areas of concern related to disability. 
These findings also support the conclusion that duration of pain, sex, and experimental pain 
sensitivity are not central to understanding pain-related disability among people with chronic 
orofacial pain. I surmise that the experience of people with acute pain or recently developed 
chronic pain (at 6 months) may differ.  
Future Research 
There are several next steps to further inform clinicians and researchers in the area of 
pain-related disability. Primarily, researchers can confirm the relationship reported here by 
measuring these factors in a longitudinal study design. The OPPERA study included a 
prospective study of 3,258 people who were pain-free at enrollment and 208 people developed 
TMD symptoms. Analysis examining baseline measures of the same variables measured in this 
project and measures repeated at onset of symptoms would provide insight into the relationship 
between factors identified here and the onset of pain-related disability. In future cohort studies, 
measuring pain-related disability, psychological distress and jaw functional limitation at multiple 
time points would allow for conclusions about how these factors influence one another and 
fluctuate over time.  
Beyond these tasks, intervention studies attempting to reduce pain-related disability 
should explore interventions on the factors identified in this research. Measuring and targeting 
features associated with pain-related disability can be accomplished in the clinical and research 
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setting and should be a priority for interventions in order to reduce the public health burden of 
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